Fuel Performance Solutions (IFUE) S-1/A 18 Nov 14 IPO registration (amended) Financial data

Document_and_Entity_Informatio

Document and Entity Information	9 Months Ended
	Sep. 30, 2014
Document And Entity Information	'
Entity Registrant Name	'FUEL PERFORMANCE SOLUTIONS, INC.
Entity Central Index Key	'0001078723
Document Type	'S-1
Document Period End Date	30-Sep-14
Amendment Flag	'true
Amendment Description	'Amendment
Current Fiscal Year End Date	'--12-31
Is Entity a Well-known Seasoned Issuer?	'No
Is Entity a Voluntary Filer?	'No
Is Entity's Reporting Status Current?	'Yes
Entity Filer Category	'Smaller Reporting Company

BALANCE_SHEETS

BALANCE SHEETS (USD $)	Sep. 30, 2014	Dec. 31, 2013	Dec. 31, 2012
Current assets	'	'	'
Cash and cash equivalents	$899,806	$216,913	$51,346
Accounts receivable	313,665	10,781	112,174
Inventory	44,205	33,784	60,229
Deferred financing cost	153,673	'	'
Prepaid expenses and other assets	102,511	28,284	25,957
Total Current Assets	1,513,860	289,762	249,706
Goodwill	2,211,805	2,211,805	2,211,805
Total Assets	3,725,665	2,501,567	2,461,511
Current liabilities	'	'	'
Accounts payable	363,544	350,984	427,868
Accrued compensation	730,692	742,465	542,468
Note payable to a related party	'	550,000	200,000
Deferred revenue	'	2,998,242	2,998,242
Derivative liability	639,637	'	'
Other accrued expenses	190,000	190,000	190,000
Other current liabilities	8,332	'	'
Total Current Liabilities	1,932,205	4,831,691	4,358,578
Convertible note payable, net of discount of $661,575 and $0, respectively	488,425	'	'
Accrued interest	12,352	'	'
Deferred rent	10,752	12,573	14,066
Deferred income taxes	771,000	723,000	659,000
Total Long-term Liabilities	1,282,529	735,573	673,066
Total Liabilities	3,214,734	5,567,264	5,031,644
Commitments and contingencies	'	'	'
Stockholders' (deficit)	'	'	'
Common stock, $0.01 par value; 350,000,000 and 250,000,000 shares authorized; 202,675,382 and 158,280,604 (net of 1,440,000 shares held in treasury) shares issued and outstanding at September 30, 2014 and December 31, 2013, respectively	2,041,154	1,597,206	1,270,503
Treasury stock	-664,600	-664,600	-664,600
Discount on common stock	-819,923	-819,923	-819,923
Additional paid-in capital	71,709,326	67,949,067	67,376,738
Accumulated deficit	-71,755,026	-71,127,447	-69,732,851
Total Stockholders' Deficit	510,931	-3,065,697	-2,570,133
Total Liabilities and Stockholders' Deficit	$3,725,665	$2,501,567	$2,461,511

BALANCE_SHEETS_Parenthetical

BALANCE SHEETS (Parenthetical) (USD $)	Sep. 30, 2014	Dec. 31, 2013	Dec. 31, 2012
Current liabilities	'	'	'
Convertible note payable, net of discount	$661,575	$0	$0
Stockholders' (deficit)	'	'	'
Common stock, par value	$0.01	$0.01	$0.01
Common stock, shares authorized	350,000,000	250,000,000	250,000,000
Common stock, shares issued	202,675,382	158,280,604	125,610,284
Common stock, shares outstanding	202,675,382	158,280,604	125,610,284
Treasury stock, shares	1,440,000	1,440,000	1,440,000

STATEMENTS_OF_OPERATIONS

STATEMENTS OF OPERATIONS (USD $)	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013	Dec. 31, 2013	Dec. 31, 2012
Statements Of Operations	'	'	'	'	'	'
Net Revenues	$677,105	$59,463	$1,506,198	$384,289	$704,189	$335,096
Operating expenses:	'	'	'	'	'	'
Cost of operations	-440,965	-33,213	-1,073,505	-305,786	603,189	243,642
Selling, general and administrative expense	-434,059	-313,362	-3,561,484	-1,131,707	1,431,695	1,957,531
Gain on accounts payable write off	59,899	'	59,899	'	'	'
Gain on deferred revenue write off	'	'	2,998,242	'	'	'
Total operating expenses	-815,125	-346,575	-1,576,848	-1,437,493	2,034,884	2,201,173
Net loss from operations	-138,020	-287,112	-70,650	-1,053,204	-1,330,695	-1,866,077
Interest income (expense), net	-54,193	17	-54,020	79	99	160
Gain (loss) on derivative liability	234,591	'	-67,409	'	'	'
Loss on conversion of debt from a related party	'	'	-387,500	'	'	'
Net income (loss) before income taxes	42,378	-287,095	-579,579	-1,053,125	-1,330,596	-1,865,917
Income tax provision	16,000	16,000	48,000	48,000	64,000	64,000
Net income (loss)	$26,378	($303,095)	($627,579)	($1,101,125)	($1,394,596)	($1,929,917)
Basic and diluted net income (loss) per common share	$0	$0	$0	($0.01)	($0.01)	($0.02)
Weighted-average common shares outstanding, basic and diluted	'	'	'	'	133,559,623	118,911,070
Weighted-average common shares outstanding, basic	202,675,382	135,467,960	194,309,478	130,725,783	'	'
Weighted-average common shares outstanding, diluted	218,479,480	135,467,960	194,309,478	130,725,783	'	'

STATEMENT_OF_STOCKHOLDERS_EQUI

STATEMENT OF STOCKHOLDER'S EQUITY (DEFICIT) (Unaudited) (USD $)	Common Stock	Treasury Stock	Discount on Common Stock	Additional Paid-In Capital	Accumulated Deficit	Total
Beginning Balance, Amount at Dec. 31, 2011	$1,164,753	($664,600)	($819,923)	$66,597,635	($67,802,934)	($1,525,069)
Beginning Balance, Shares at Dec. 31, 2011	116,475,284	'	'	'	'	'
Issuance of stock for cash, Shares	9,975,000	'	'	'	'	'
Issuance of stock for cash, Amount	99,750	'	'	710,250	'	810,000
Issuance of stock for conversion of debt, shares	600,000	'	'	'	'	'
Issuance of stock for conversion of debt, amount	6,000	'	'	54,000	'	60,000
Expense relating to stock option grants	'	'	'	14,853	'	14,853
Net loss	'	'	'	'	-1,929,917	-1,929,917
Ending Balance, Amount at Dec. 31, 2012	1,270,503	-664,600	-819,923	67,376,738	-69,732,851	-2,570,133
Ending Balance, Shares at Dec. 31, 2012	127,050,284	'	'	'	'	'
Issuance of stock for cash, Shares	32,482,820	'	'	'	'	'
Issuance of stock for cash, Amount	324,828	'	'	557,329	'	882,157
Expense relating to stock option grants	'	'	'	'	'	'
Issuances of stock for services, Shares	187,500	'	'	'	'	'
Issuances of stock for services, Amount	1,875	'	'	15,000	'	16,875
Net loss	'	'	'	'	-1,394,596	-1,394,596
Ending Balance, Amount at Dec. 31, 2013	1,597,206	-664,600	-819,923	67,949,067	-71,127,447	-3,065,697
Ending Balance, Shares at Dec. 31, 2013	159,720,604	'	'	'	'	'
Issuance of stock for cash, Shares	31,894,778	'	'	'	'	'
Issuance of stock for cash, Amount	318,948	'	'	508,776	'	827,724
Issuance of stock for conversion of debt, shares	12,500,000	'	'	'	'	'
Issuance of stock for conversion of debt, amount	125,000	'	'	812,500	'	937,500
Expense relating to stock option grants	'	'	'	2,438,983	'	2,438,983
Net loss	'	'	'	'	-627,579	-627,579
Ending Balance, Amount at Sep. 30, 2014	$2,041,154	($664,600)	($819,923)	$71,709,326	($71,755,026)	$510,931
Ending Balance, Shares at Sep. 30, 2014	204,115,382	'	'	'	'	'

STATEMENTS_OF_CASH_FLOWS

STATEMENTS OF CASH FLOWS (USD $)	9 Months Ended		12 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Dec. 31, 2013	Dec. 31, 2012
Cash flows from operating activities:	'	'	'	'
Net loss	($627,579)	($1,101,125)	($1,394,596)	($1,929,917)
Adjustments to reconcile net loss to net cash used in operating activities:	'	'	'	'
Non-cash stock-based compensation	'	16,875	16,875	'
Non-cash option expense	2,438,983	'	'	14,853
Gain on deferred revenue write off	-2,998,242	'	'	'
Loss on conversion of debt from a related party	387,500	'	'	'
Income tax provision	48,000	48,000	64,000	64,000
Loss on derivative liability	67,409	'	'	'
Gain on writeoff of accounts payable	-59,899	'	'	'
Amortization of debt discount	31,103	'	'	'
Amortization of deferred financing cost	10,877	'	'	'
Change in assets and liabilities:	'	'	'	'
Accounts receivable	-302,884	85,043	101,393	-26,952
Inventory	-10,421	25,297	26,445	12,334
Prepaid expenses and other assets	-74,227	4,568	-2,327	-6,345
Accounts payable	72,459	63,624	-76,884	155,022
Accrued compensation	-11,773	153,357	199,997	367,390
Accrued interest payable	12,352	'	'	'
Deferred rent	-1,821	-1,032	-1,493	14,066
Net cash used in operating activities	-1,018,163	-705,393	-1,066,590	-1,335,549
Cash flows from financing activities:	'	'	'	'
Gross proceeds from issuance of convertible note	1,000,000	'	'	'
Proceeds from issuance of note payable to related parties	'	350,000	450,000	260,000
Note payable from related party	'	-100,000	-100,000	'
Deposits received for stock purchase	8,332	'	'	'
Payments made for deferred financing cost	-135,000	'	'	'
Proceeds from issuance of common stock	827,724	466,114	882,157	810,000
Net cash provided by financing activities	1,701,056	716,114	1,232,157	1,070,000
Net decrease in cash and cash equivalents	682,893	10,721	165,567	-265,549
Cash and cash equivalents, beginning	216,913	51,346	51,346	316,895
Cash and cash equivalents, ending	899,806	62,067	216,913	51,346
Cash paid during the year ended December Thirty One:	'	'	'	'
Interest	'	'	'	'
Income taxes	'	'	'	'
Non-cash transactions:	'	'	'	'
Note payable to related party conversion into common stock	'	'	'	60,000
Conversion of related party notes to common stock	550,000	'	'	'
Debt discount due to derivative liability	295,773	'	'	'
Debt discount due to warrant issued with convertible note	246,905	'	'	'
Convertible note original issuance cost	150,000	'	'	'
Deferred financing cost due to derivative liability for warrant	$29,550	'	'	'

Nature_of_Business_and_Signifi

Nature of Business and Significant Accounting Policies	12 Months Ended
	Dec. 31, 2013
Notes to Financial Statements	'
Nature of Business and Significant Accounting Policies	'
	Nature of Business
	Fuel Performance Solutions, Inc. (“FPS,” “we” or the “Company”) is a company that was incorporated under the laws of the State of Nevada on April 9, 1996. On February 5, 2014, the Company changed its name from International Fuel Technology, Inc. to Fuel Performance Solutions, Inc. We have developed a family of fuel additive product formulations. These unique fuel blends have been created to improve fuel economy, enhance lubricity (reducing engine wear and tear) and lower harmful engine emissions, while decreasing reliance on petroleum-based fuels through the use of more efficient, alternative and renewable fuels. We began transitioning from a development stage technology company to a commercial entity during 2002 and have been increasing our product marketing and sales efforts since. We are now focused on continuing to develop the body of evidence of the efficacy of our products applicable to a wide range of markets and industries within these markets through additional industry specific laboratory testing and customer field-based demonstration trials. In addition, we are continuing to strengthen our distributor and customer contact base. Marketing and sales efforts, in conjunction with the additional industry specific testing, will complete our transition to a commercial enterprise.
	During 2013, our net revenues were split in the following manner: 9% to United States end-user customers and 91% to international distributors and end-user customers. 92% of our net revenues for 2013 were concentrated among 5 customers.
	During 2012, our net revenues were split in the following manner: 17% to United States end-user customers and 83% to international distributors and end-user customers. 90% of our net revenues for 2012 were concentrated among 3 customers.
	At December 31, 2012, 95% of our accounts receivable balance was attributable to 1 customer.
	Customers whose revenues exceeded 10% of our total revenues for 2013 and 2012, respectively, are listed below:
	Customer Name	2013			2012
	Nordmann, Rassmann		74	%		59	%
	Schnucks Markets, Inc.		*			14	%
	Next Group Brazil		12	%		-
	East Midlands Trains Limited		-			17	%
	*Below 10% threshold for applicable period
	Our product line revenues for 2013 and 2012 have not been significant. See the table below for a breakdown of our product line revenues:
		2013						2012
	FPS Product	$				%		$		%
	DiesoLiFTTM 10	$	55,763			8	%	$	107,210	32	%
	PerfoLiFT BD-Series		633,931			90	%		209,394	62	%
	Other		14,495			2	%		18,492	6	%
	Total revenues	$	704,189			100	%	$	335,096	100	%
	Net revenues related to shipments into various foreign countries were $640,004 and $279,470  during 2013 and 2012, respectively. The following table breaks out net revenues by foreign country:
	Country	2013			2012
	Brazil	$	88,361		$	-
	China		-			-
	Czech. Republic		139,640			63,513
	Cyprus		12,175			5,028
	France		14,495			18,492
	Germany		310,649			135,357
	Romania		68,631			-
	United Kingdom		6,053			57,080
		$	640,004		$	279,470
	We currently utilize Brenntag as our contracted product manufacturer. Brenntag independently purchases required raw materials to manufacture our product. For the years ended December 31, 2013 and 2012, 100% of our product manufacturing has been handled by Brenntag.
	Summaries of our significant accounting policies follow:
	Use of Estimates in the Preparation of Financial Statements
	The preparation of financial statements in conformity with United States generally accepted accounting principles (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
	Reclassifications
	Certain prior year amounts have been reclassified to conform to the current year presentation.
	Concentration of Credit Risk
	Financial instruments which potentially subject the Company to concentrations of credit risk consist of cash and trade receivables. The Company places its cash with high credit quality financial institutions. At times such cash may be in excess of the FDIC limit. With respect to trade receivables, the Company routinely assesses the financial strength of its customers and, as a consequence, believes that the receivable credit risk exposure is limited.
	Related Parties
	A party is considered to be related to the Company if the party directly or indirectly or through one or more intermediaries, controls, is controlled by, or is under common control with the Company. Related parties also include principal owners of the Company, its management, members of the immediate families of principal owners of the Company and its management and other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests. A party which can significantly influence the management or operating policies of the transacting parties or if it has an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests is also a related party.
	Revenue Recognition
	We recognize revenue from the sale of our products when the price is fixed and determinable, persuasive evidence of an arrangement exists, the products are shipped, and title and risk of loss has passed to the buyer and collectability of the resulting receivable is reasonably assured. A majority of our revenues is from sales to product distributors. Product distributors do not have the option to return product that is not immediately sold to an end-user. Therefore, our revenue recognition is not conditional on whether a distributor is able to sell product to an ultimate product end-user. Our sales policies for end-users are consistent with product distributor sales policies.
	Beginning in May 2013, as an effort to address our outstanding payable balance with and at the request of our product manufacturer, our non-United States customers began remitting receivable payments directly to our product manufacturer in lieu of remitting payment directly to us. Under this arrangement, we still maintained the risks and benefits related to sending the product to each customer and thus recorded sales revenues (and associated cost of sales) applying the gross reporting treatment for each transaction pursuant to ASC 605-45, “Principal Agent Considerations.”
	Cash and Cash Equivalents
	Cash and cash equivalents include cash on hand and temporary investments with a maturity of three months or less. We maintain cash in a bank account, which, at times, exceeds federally insured limits. We have experienced no losses relating to these excess amounts of cash in a bank.
	We utilize a cash management program that assesses daily cash requirements. Excess funds are invested in overnight repurchase agreements backed by United States Treasury securities. Repurchase agreements are not deposits, are not insured or guaranteed by the United States government, the Federal Deposit Insurance Corporation or any other government agency, and involve investment risk including possible loss of principal.
	Accounts Receivable
	An allowance for doubtful accounts is maintained at a level we believe sufficient to cover potential losses based on historical trends and known current factors impacting our customers. We have determined that an allowance for doubtful accounts was not necessary as of December 31, 2013 and 2012.
	Inventory
	Inventory, which consists of finished product, is valued at the lower of cost or market, based on the first-in, first-out (“FIFO”) method, or market, and reflects the purchased cost from vendors. Although we maintain minimal inventory levels in the United States at external storage facilities, the majority of our inventory is manufactured based on customer demand and immediately shipped to customers upon completion. The raw material components required to manufacture our products reside at our product manufacturer’s facilities.
	Goodwill
	The Company accounts for goodwill and intangible assets in accordance with ASC 350 "Intangibles-Goodwill and Other" ("ASC 350"). ASC 350 requires that goodwill and other intangibles with indefinite lives be tested for impairment annually or on an interim basis if events or circumstances indicate that the fair value of an asset has decreased below its carrying value. In addition, ASC 350 requires that goodwill be tested for impairment at the reporting unit level (operating segment or one level below an operating segment) on an annual basis and between annual tests when circumstances indicate that the recoverability of the carrying amount of goodwill may be in doubt. Application of the goodwill impairment test requires judgment, including the identification of reporting units; assigning assets and liabilities to reporting units, assigning goodwill to reporting units, and determining the fair value. Significant judgments required to estimate the fair value of reporting units include estimating future cash flows, determining appropriate discount rates and other assumptions. Changes in these estimates and assumptions or the occurrence of one or more confirming events in future periods could cause the actual results or outcomes to materially differ from such estimates and could also affect the determination of fair value and/or goodwill impairment at future reporting dates.
	The Company completed an evaluation of goodwill at December 31, 2013 and 2012 and determined that there was no impairment. The Company employed a qualitative evaluation for 2013 analysis. For the 2012 evaluation, a net book value of less than $0 was determined using the Step 1 test. The Company determined that its qualitative evaluation for 2012 resulted in a less than more likely than not determination of impairment, resulting in the Step 2 test being bypassed.
	Income Taxes
	The Company accounts for income taxes utilizing ASC 740, “Income Taxes” (“ASC 740”). ASC 740 requires the measurement of deferred tax assets for deductible temporary differences and operating loss carry forwards, and of deferred tax liabilities for taxable temporary differences. Measurement of current and deferred tax liabilities and assets is based on provisions of enacted tax law. The effects of future changes in tax laws or rates are not included in the measurement. The Company recognizes the amount of taxes payable or refundable for the current year and recognizes deferred tax liabilities and assets for the expected future tax consequences of events and transactions that have been recognized in the Company’s financial statements or tax returns. The Company currently has substantial NOL carry forwards. The Company has recorded a 100% valuation allowance against net deferred tax assets due to uncertainty of their ultimate realization. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized.
	Research and Development
	Research and development costs are expensed as incurred. Expense for services received from external vendors for 2013 and 2012 was $80,689 and $96,117, respectively.
	Advertising Expenses
	Advertising costs are expensed as incurred and amounted to $56,219 and $73,772 in 2013 and 2012, respectively.
	Basic and Diluted Net Earnings (Loss) Per Common Share
	The Company accounts for earnings per share pursuant to ASC 260, “Earnings per Share,” which requires disclosure on the financial statements of "basic" and "diluted" earnings (loss) per share. Basic earnings (loss) per share are computed by dividing net income (loss) by the weighted average number of common shares outstanding for the year. Diluted earnings (loss) per share is computed by dividing net income (loss) by the weighted average number of common shares outstanding plus common stock equivalents (if dilutive) related to stock options and warrants for each year. As there was a net loss for the periods, basic and diluted loss per share is the same for the years ended December 31, 2013 and 2012, respectively.
	Fair Value of Financial Instruments
	The Company measures its financial assets and liabilities in accordance with the requirements of ASC 820, “Fair Value Measurements and Disclosures” (“ASC 820”). ASC 820 clarifies the definition of fair value, prescribes methods for measuring fair value, and establishes a fair value hierarchy to classify the inputs used in measuring fair value as follows:
Level 1 – Quoted prices are available in active markets for identical assets or liabilities as of the reporting date. Active markets are those in which transactions for the asset or liability occur in sufficient frequency and volume to provide pricing information on an ongoing basis. Level 1 primarily consists of financial instruments such as exchange-traded derivatives, marketable securities and listed equities.
Level 2 - Pricing inputs are other than quoted prices in active markets included in level 1, which are either directly or indirectly observable as of the reported date and includes those financial instruments that are valued using models or other valuation methodologies. These models are primarily industry-standard models that consider various assumptions, including quoted forward prices for commodities, time value, volatility factors, and current market and contractual prices for the underlying instruments, as well as other relevant economic measures. Substantially all of these assumptions are observable in the marketplace throughout the full term of the instrument, can be derived from observable data or are supported by observable levels at which transactions are executed in the marketplace. Instruments in this category generally include non-exchange-traded derivatives such as commodity swaps, interest rate swaps, options and collars.
Level 3 – Pricing inputs include significant inputs that are generally less observable from objective sources. These inputs may be used with internally developed methodologies that result in management’s best estimate of fair value.
Employee Stock-Based Compensation
The Company accounts for stock-based compensation in accordance with ASC 718, “Compensation-Stock Compensation” (“ASC 718). ASC 718 requires companies to measure the cost of employee services received in exchange for an award of equity instruments, including stock options, based on the grant date fair value of the award and to recognize it as compensation expense over the period the employee is required to provide service in exchange for the award, usually the vesting period.
Non-Employee Stock-Based Compensation
The Company accounts for stock-based compensation in accordance with the provision of ASC 505, “Equity Based Payments to Non-Employees” (“ASC 505”), which requires that such equity instruments are recorded at their fair value on the measurement date. The measurement of stock-based compensation is subject to periodic adjustment as the underlying equity instruments vest.
Recently Issued Accounting Pronouncements
Management does not believe that any recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company's financial statements.

Basis_of_Presentation

Basis of Presentation	9 Months Ended
	Sep. 30, 2014
Notes to Financial Statements	'
Basis of Presentation	'
	The interim financial statements included herein have been prepared by Fuel Performance Solutions, Inc. (formerly known as International Fuel Technology, Inc.) (“FPS,” “we” or the “Company,”) without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with United States generally accepted accounting principles (“GAAP”) have been condensed or omitted pursuant to such rules and regulations, although we believe that the disclosures are adequate to make the information presented not misleading.
	These statements reflect all adjustments, consisting of normal recurring adjustments, which in the opinion of management are necessary for fair presentation of the information contained therein. Interim results are not necessarily indicative of results for a full year. We suggest that these financial statements be read in conjunction with the financial statements and notes thereto included in the comprehensive annual report on Form 10-K for the years ended December 31, 2013 and 2012 and the quarterly periods ended March 31, 2013, June 30, 2013 and September 30, 2013, filed with the SEC on May 15, 2014. We follow the same accounting policies in preparation of interim reports as we do in our annual reports.

Substantial_Doubt_About_Abilit

Substantial Doubt About Ability to Continue as a Going Concern	9 Months Ended	12 Months Ended
	Sep. 30, 2014	Dec. 31, 2013
Notes to Financial Statements	'	'
Substantial Doubt About Ability to Continue as a Going Concern	'	'
	Our financial statements are presented on the going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. We have incurred significant losses since inception and currently have, and previously from time to time have had, limited funds with which to operate. These conditions raise substantial doubt as to the Company’s ability to continue as a going concern. Management is in the process of executing a strategy based upon marketing technologies that offer enhanced engine performance and greater fuel economy along with pollution control benefits. We have several technologies in the commercialization phase and in development. We have received necessary regulatory approvals for our products currently in the commercialization phase. We are selling our products directly to the commercial marketplace. We expect to increase our sales to the marketplace, eventually generating a level of revenues sufficient to meet our cash flow and earnings requirements. Until such time, we are dependent on external sources of capital to help fund the operations of the Company.	Our financial statements are presented on the going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. We have incurred significant losses since inception and currently have and previously from time to time have had limited funds with which to operate. These conditions raise substantial doubt as to the Company’s ability to continue as a going concern. Management is in the process of executing a strategy based upon marketing technologies that offer enhanced engine performance and greater fuel economy along with pollution control benefits. We have several technologies in the commercialization phase and in development. We have received necessary regulatory and commercial acceptance for our products currently in the commercialization phase. During the first quarter of 2002, we began selling our products directly to the commercial marketplace. We expect to increase our sales to the marketplace, eventually generating a level of revenues sufficient to meet our cash flow and earnings requirements. Until such time, we are dependent on external sources of capital to help fund the operations of the Company. Management implemented a salary deferral program for all employees during 2011 to conserve our cash position. This salary deferral program has continued.
	During the third quarter of 2014, we raised funds with the issuance of a convertible note. We have been funded since inception primarily by unregistered sales of Company restricted stock, generally to existing shareholders. We believe we still have access to capital from existing shareholders and in addition, management is in the process of executing a plan that we believe will provide us with sufficient funds to allow us to operate through the end of the third quarter of 2015. However, we can make no assurances that additional capital will be available to us from either of these sources. Therefore, if we are unable to secure additional capital, we will need to curtail operations.	We have been funded since inception primarily by unregistered sales of the Company’s restricted stock, generally to existing shareholders. Although we believe we still have access to capital from existing shareholders , we can make no assurances that, if required, additional capital will be available to us from this source. Therefore, if we are unable to achieve significant, sustained sales and revenues or secure additional capital by the end of the third quarter of 2015, we will need to curtail operations.
	The financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the possible inability of FPS to continue as a going concern.	The financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the possible inability of the Company to continue as a going concern.

Significant_Accounting_Policie

Significant Accounting Policies	9 Months Ended
	Sep. 30, 2014
Notes to Financial Statements	'
Significant Accounting Policies	'
	Derivative Financial Instruments
	The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in our statements of operations. For stock-based derivative financial instruments, the Company uses a Lattice Model option pricing model, in accordance with the Financial Accounting Standards Board (the “FASB”) Accounting Standards Codification (“ASC”) ASC 815-15, “Derivatives and Hedging,” to value the derivative instruments at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in our balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date.
	Fair Value of Financial Instruments
	The Company measures its financial assets and liabilities in accordance with the requirements of ASC 820, “Fair Value Measurements and Disclosures.” ASC 820 clarifies the definition of fair value, prescribes methods for measuring fair value, and establishes a fair value hierarchy to classify the inputs used in measuring fair value as follows:
	Level 1 - Quoted prices are available in active markets for identical assets or liabilities as of the reporting date. Active markets are those in which transactions for the asset or liability occur in sufficient frequency and volume to provide pricing information on an ongoing basis. Level 1 primarily consists of financial instruments such as exchange-traded derivatives, marketable securities and listed equities.
	Level 2 - Pricing inputs are other than quoted prices in active markets included in level 1, which are either directly or indirectly observable as of the reported date and includes those financial instruments that are valued using models or other valuation methodologies. These models are primarily industry-standard models that consider various assumptions, including quoted forward prices for commodities, time value, volatility factors, and current market and contractual prices for the underlying instruments, as well as other relevant economic measures. Substantially all of these assumptions are observable in the marketplace throughout the full term of the instrument, can be derived from observable data or are supported by observable levels at which transactions are executed in the marketplace. Instruments in this category generally include non-exchange-traded derivatives such as commodity swaps, interest rate swaps, options and collars.
	Level 3 - Pricing inputs include significant inputs that are generally less observable from objective sources. These inputs may be used with internally developed methodologies that result in management’s best estimate of fair value.
	The following table sets forth by level within the fair value hierarchy the Company’s financial assets and liabilities that were accounted for at fair value as of September 30, 2014, and December 31, 2013:
	Recurring Fair Value Measures	Level 1		Level 2		Level 3		Total
	30-Sep-14
	Derivative liability	$	-	$	-	$	639,637	$	639,637
	31-Dec-13
	Derivative liability	$	-	$	-	$	-	$	-

Stockholders_Deficit

Stockholders' Deficit	9 Months Ended										12 Months Ended
	Sep. 30, 2014										Dec. 31, 2013
Notes to Financial Statements	'										'
Stockholders' Deficit	'										'
	On May 22, 2014, we filed a certificate of amendment to our Articles of Incorporation increasing the number of our authorized shares from 250,000,000 to 350,000,000 shares with the Nevada Secretary of State.										Effective October 27, 1999, we merged with Blencathia Acquisition Corporation (“Blencathia”). Blencathia was a public shell company with immaterial assets and liabilities and 312,000 shares outstanding at the time of the merger, which it redeemed and cancelled upon the merger. In exchange, we issued 312,000 of our common shares to the prior Blencathia owner with the contractual understanding that such shares were to be sold by that owner to achieve gross cash proceeds of $500,000. Any excess proceeds were to be returned to us and any deficiency was to be made up by us issuing additional shares or paying the difference in cash. As we believed that we controlled the ultimate timing of the sale of these 312,000 shares by the prior Blencathia owner, we did not consider these shares as issued or outstanding for purposes of computing earnings per share prior to 2006.
	Non-cash stock-based compensation expense recorded in the three and nine months ended September 30, 2014 and September 30, 2013 is as follows:										In 2006, we learned that the prior Blencathia owner had, in fact, sold the 312,000 shares for aggregate proceeds of approximately $150,000, without our consent. Accordingly, in the fourth quarter of 2006, we recorded $500,000 of general expenses (representing the cost of the 1999 merger) and the deemed issuance of approximately $150,000 of common stock. The remaining $350,000 obligation was reflected as a current accrued expense. Beginning in 2006, the 312,000 shares have been reflected as outstanding for earnings per share computations. During 2009 and 2010, we made payments totaling $160,000 to the prior Blencathia owner. We did not make any payments to the prior Blencathia owner during 2011, 2012 or 2013. The related current accrued expense balance remains at $190,000 at the end of 2013. We are in negotiations with the prior Blencathia owner to resolve this obligation and may ultimately settle the obligation with either cash or equity securities with a lower market value.
		Three Months Ended			Three Months Ended		Nine Months		Nine Months		During 2013, we sold an aggregate total of 32,482,820 shares to accredited investors which yielded aggregate proceeds of $882,157.
		September 30,			September 30,		Ended		Ended
		2014			2013		September 30,		September 30,		A detachable warrant to purchase a share of our common stock accompanied certain share purchases in these offerings. The 4,875,000 aggregate warrants issued during 2013 each have an exercise price of $0.10 and were exercisable immediately and up to 5 years.
							2014		2013
											On April 12, 2013, the Company’s Board authorized and approved the extension of expiration date and change of exercise price for 2,000,000 warrants granted to a warrant holder for the purchase of the Company’s common stock. The outstanding share purchase warrants originally had a March 23, 2014 expiration and an exercise price of $0.25. Now the warrant shall expire on April 11, 2018 with an exercise price of $0.226. The Company analyzed the modification under ASC 718 and ASC 505 and determined no gain or loss is recognized upon the modification due to the warrant having been issued to an investor and investor awards are not subject to either ASC 718 or ASC 505.
	Awards to employees	$	71,191		$	-	$	2,355,669	$	-
	Awards to non-employees		-			-		83,314		16,875	During 2013, we issued a cumulative total of 187,500 common shares to a non-employee consulting entity for services. These shares were valued at the respective settlement dates’ quoted market prices and resulted in an aggregate of $16,875 of recorded non-cash stock-based compensation expense during 2013.
	Total non-cash stock-based compensation expense	$	71,191		$	-	$	2,438,983	$	16,875
											During the third quarter of 2013, 250,000 warrants associated with a prior financing expired.
	Employee and Director awards
											During 2012, we sold a total of 9,975,000 shares to accredited investors which yielded aggregate proceeds of $810,000. A detachable warrant to purchase a share of our common stock accompanied certain share purchases in these offerings. The 9,825,000 aggregate warrants each have an exercise price of $0.10 and were exercisable immediately and up to 5 years.
	During the three months ended September 30, 2014, we did not issue any options to employees or Directors for Director-related services.
											During 2012, an aggregate total of $60,000 of notes payable from related parties was converted to equity via the issuance of 600,000 shares of our stock based on the then-market price of $0.10 per share. The terms of these loans did not require the payment of interest and did not require repayment of the principal by a certain date.
	During the three months ended June 30, 2014, we issued 10,000,000 options to employees and 5,000,000 options to Directors for Director-related services.
											No shares were issued to Directors for Director-related services in 2013 or 2012.
	During the three months ended March 31, 2014, we issued 12,401,200 options to employees and 2,624,800 options to Directors for Director-related services. These option grants were issued in conjunction with the cancellation of 7,070,400 options that had previously been issued to employees and Directors.
											As of December 31, 2013 and 2012, we have 21,595,750 and 16,970,750 warrants outstanding, respectively. These warrants were issued as part of equity funding efforts that occurred in 2009, 2011, 2012 and 2013.
	No stock options were granted to employees or to Directors for Director-related services during the nine months ended September 30, 2013.
	During the three months ended September 30, 2014, 100,000 options previously granted to a non-employee Director expired. During the three months ended March 31, 2014, 20,000 options previously granted to an employee expired. These options had vested before expiration.										Year Warrants Issued	No. of Warrants Issued			Warrant Exercise Price		Warrant Expiration Date
	The following tables summarize information about stock options issued to employees and Directors during the nine months ended September 30, 2014:										2009		4,325,000		$	0.25		2014
											2011		2,570,750		$	0.25		2016
		Shares			Weighted-average exercise price		Weighted-average exercise life		Intrinsic value		2011		250,000		$	0.25		2013
											2012		9,825,000		$	0.1		2017
	Outstanding at December 31, 2013		9,489,120		$	0.41		1.06	$	-	2013		4,875,000		$	0.1		2018
	Granted		30,026,000		$	0.1		4.49			No warrants were exercised during 2013 or 2012.
	Cancelled		(7,070,400	)	$	0.39		-
	Expired		(120,000	)	$	0.25		-			Further information relating to warrants is as follows:
	Outstanding at September 30, 2014		32,324,720		$	0.13		4.19	$	671,031
															Weighted-		Weighted-
	Options exercisable at September 30, 2014		28,991,386		$	0.13		4.16				Number			Average		Average
	Options exercisable at December 31, 2013		9,489,120		$	0.41		1.06				of			Exercise		Exercise
												Shares			Price		Life
	The following table provides the primary assumptions used to value employee and Director non-cash stock-based compensation for the nine months ended September 30, 2014:										Outstanding at December 31, 2011		7,145,750		$	0.25		3.04
											Granted		9,825,000		$	0.1		4.66
		For the Nine Months Ended September 30, 2014									Outstanding at December 31, 2012		16,970,750		$	0.16		3.55
											Granted		4,875,000		$	0.1		4.26
	Weighted-average fair value of options granted	$	0.09								Expired		(250,000	)	$	0.25		-
	Weighted-average assumptions:										Outstanding at December 31, 2013		21,595,750		$	0.15		3.35
	Risk-free interest rate		0.65	%
	Dividend yield		-								The intrinsic value (difference between the warrant exercise price and our stock share price) attributable to warrants issued was $0 at both December 31, 2013 and 2012.
	Expected volatility		1.09
	Expected option life (years)		2.58								Equity Commitment
	Non-employee awards										Effective December 11, 2007, we received an investment commitment from Rex Carr, a Director of FPS and a holder of over 5% of our common stock. Pursuant to the terms of the commitment, Mr. Carr has agreed to invest up to an aggregate of $1,000,000 in FPS, at such time or times as we may request, in the form of a purchase or purchases of restricted common stock of FPS. FPS may elect to draw from the commitment at one time or from time to time; provided, however, that the aggregate of such draws may not exceed $1,000,000. If and when we elect to utilize available commitment funds, we will issue to Mr. Carr that number of shares of restricted common stock of FPS equal to the value of the investment then provided to FPS. The number of shares to be issued will be calculated based on the closing price of our common stock as quoted on OTC Market Group’s OTC Pink Marketplace on the date of the sale. There is no stipulation regarding the duration of this commitment. As of December 31, 2013 and 2012 the amounts available under this commitment were $500,000 and $800,000, respectively.
	During the three months ended September 30, 2014, we did not issue any options to non-employee consultants for services.
	During the three months ended June 30, 2014, we did not issue any options to non-employee consultants for services.
	During the three months ended March 31, 2014, we issued 1,555,000 options to non-employee consultants for services. These option grants were issued in conjunction with the cancellation of 1,352,000 options that had previously been issued to a non-employee.
	No stock options were granted to non-employee consultants for services during the nine months ended September 30, 2013.
	During the three months ended June 30, 2014, 1,015,600 options previously granted to non-employee consultants for services expired. 1,010,400 of these options had vested before expiration.
	During the three months ended March 31, 2014, 1,000,000 options previously granted to non-employee consultants for services expired. These options had vested before expiration.
	Services performed by non-employees who were granted options include product/distribution consulting and investor relations related services. The weighted-average fair value for such options that have had a fair value calculation applied ($0.05 for the nine months ended September 30, 2014) was estimated at the date of grant using a Black-Scholes option pricing model. The following weighted-average assumptions were used for the first quarter of 2014 grants: risk-free interest rate of 1.08%, volatility factor of 1.03, and a weighted-average expected life of the option of approximately 3.68 years.
	The following table summarizes information about stock options issued to non-employees during the nine months ended September 30, 2014:
		Shares			Weighted-average exercise price		Weighted-average exercise life		Intrinsic value
	Outstanding at December 31, 2013		4,137,599		$	0.46		0.73	$	-
	Granted		1,555,000		$	0.08		2.99
	Cancelled		(1,352,000	)	$	0.48		-
	Expired		(2,015,600	)	$	0.47		-
	Outstanding at September 30, 2014		2,324,999		$	0.19		2.26	$	24,500
	Options exercisable at September 30, 2014		2,324,999		$	0.19		2.26
	Options exercisable at December 31, 2013		4,132,399		$	0.46		0.73
	Sales of common stock
	During the three months ended June 30, 2014, we received proceeds of $226,284 for the sale of 5,391,795 restricted shares of our common stock to a small group of accredited investors. We also received $8,332 in funds as deposits to be applied to the purchase of 83,316 restricted shares of common stock.
During the three months ended March 31, 2014, we received proceeds of $601,440 for the sale of 26,502,983 restricted shares of our common stock to a small group of accredited investors.
See Note 5 – Equity Commitment and Related Party Transactions for a description of other equity transactions FPS effected during the nine months ended September 30, 2014.

Stock_Options

Stock Options	12 Months Ended
	Dec. 31, 2013
Notes to Financial Statements	'
Stock Options	'
	Long Term Incentive Plan
	On October 23, 2001, the Board adopted our Long Term Incentive Plan (“LTIP”). The Board is responsible for the administration of this LTIP, and is the approval authority for all option grant awards under this plan. Subject to the express provisions of the LTIP, the Board shall have full authority and sole and absolute discretion to interpret and amend this LTIP, to prescribe, amend and rescind rules and regulations relating to it, and to make all other determinations which it believes to be necessary or advisable in administering this LTIP.
	On October 22, 2006, our Board adopted the Amended and Restated LTIP. This plan expires on October 21, 2016.
	The maximum number of shares of common stock as to which awards may be granted under this plan, subject to subsequent amendments, is 18,200,000 shares (updated to reflect the 4% dividend issued during the first quarter of 2009). The common stock issued upon exercise of options or on grant of stock awards may be shares previously authorized but not yet issued or shares which have been issued and reacquired by the Company as treasury stock. The Board may increase the maximum number of shares of common stock as to which awards may be granted at such time as it deems advisable.
	The following tables summarize information about stock options issued to employees and Directors during the 2 years ended December 31, 2013:
			Shares				Exercise price per share			Weighted-average exercise price
	Outstanding at December 31, 2011			11,993,120			$	0.10-0.96		$	0.43
	Granted			50,000			$	0.09		$	0.09
	Expired			(546,000	)		$	0.15-0.72		$	0.52
	Outstanding at December 31, 2012			11,497,120			$	0.09-0.96		$	0.43
	Expired			(2,008,000	)		$	0.21-0.96		$	0.53
	Outstanding at December 31, 2013			9,489,120			$	0.09-0.50		$	0.41
	Options exercisable at December 31, 2013			9,489,120			$	0.09-0.50		$	0.41
	Options exercisable at December 31, 2012			11,497,120			$	0.09-0.96		$	0.43
	The following table summarizes information about employee stock options outstanding at December 31, 2013:
				Options Outstanding									Options Exercisable
				Number outstanding at				Weighted-average remaining			Weighted-average		Number exercisable at		Weighted-average
	Exercise price range			31-Dec-13				contractual life (years)			exercise price		31-Dec-13		exercise price
	$0.09 - $0.25				2,435,760				1		$	0.2		2,435,760	$	0.2
	$0.26 - $0.50				7,053,360				1		$	0.48		7,053,360	$	0.48
					9,489,120				1		$	0.41		9,489,120	$	0.41
	The following table summarizes information about employee stock options outstanding at December 31, 2012:
				Options Outstanding									Options Exercisable
				Number outstanding at				Weighted-average remaining			Weighted-average		Number exercisable at		Weighted-average
	Exercise price range			31-Dec-12				contractual life (years)			exercise price		31-Dec-12		exercise price
	$0.09 - $0.50				11,341,120				2		$	0.42		11,341,120	$	0.42
	$0.51 - $1.00				156,000				1		$	0.96		156,000	$	0.96
					11,497,120				2		$	0.43		11,497,120	$	0.43
	The following table summarizes information about stock options issued to non-employees during the 2 years ended December 31, 2013:
							Exercise price per share			Weighted-average exercise price
			Shares
	Outstanding at December 31, 2011			4,785,599			$	0.25-0.96		$	0.49
	Granted			150,000			$	0.25		$	0.25
	Expired			(154,000	)		$	0.29-0.38		$	0.32
	Outstanding at December 31, 2012			4,781,599			$	0.25-0.96		$	0.49
	Expired			(644,000	)		$	0.25-0.96		$	0.57
	Outstanding at December 31, 2013			4,137,599			$	0.25-0.50		$	0.46
	Options exercisable at December 31, 2013			4,132,399			$	0.25-0.50		$	0.46
	Options exercisable at December 31, 2012			4,776,399			$	0.25-0.96		$	0.49
	Stock option expense recorded in 2013 and 2012 is as follows:
			Year Ended December 31, 2013				Year Ended December 31, 2012
	Awards to employees/Directors		$	-			$	3,396
	Awards to non-employees			-				11,457
	Stock option modifications			-				-
	Total non-cash stock-based compensation expense		$	-			$	14,853
	Employee and Director Awards
	In 2013, we did not grant any options to employees or to Directors in their capacity as Directors. In addition, 2,008,000 fully vested options previously granted to employees and Directors (in their capacity as directors) expired during 2013.
	In 2012, we did not grant any options to employees. During 2012, we granted 50,000 options to Directors in their capacity as Directors. These grants vested in 2012 and expire in 2017. In addition, 546,000 fully vested options previously granted to employees and Directors (in their capacity as directors) expired during 2012.
	The following table provides the primary assumptions used to value employee and Director non-cash stock-based compensation for the years indicated:
		Year Ended		Year Ended
		31-Dec-13		31-Dec-12
	Weighted-average fair value of options granted	NA		$	0.07
	Weighted-average assumptions:
	Risk-free interest rate	NA			0.74	%
	Dividend yield	NA			-
	Expected volatility	NA			1.03
	Expected option life (years)	NA			5
	As of December 31, 2013 and 2012, there was $0 of total unrecognized compensation cost related to outstanding options granted to employees and Directors. All options previously granted to employees and Directors were fully vested in these respective periods.
	Non-employee awards
	We did not grant any stock options to non-employees during 2013. However, 644,000 fully vested options previously granted to non-employees expired in 2013.
	In 2012, we granted 150,000 stock options to a non-employee. This grant vested in 2012 and expired in 2013. In addition, 154,000 fully vested options previously granted to non-employees expired in 2012.
	We did not receive proceeds for stock options exercised during 2013 or 2012, as no options were exercised.
	Services performed by non-employees who were granted options include product/distribution consulting, technology consulting, investor relations and legal services. The weighted-average fair value for such options that have had a fair value calculation applied (NA for 2013 and $0.08 for 2012) was estimated at the date of grant using a Black-Scholes option pricing model. The following weighted-average assumptions were used for the 2012 grant: risk-free interest rate of 0.25%, volatility factor of 0.99, and a weighted-average expected life of the option of approximately 1.89 years.
The weighted-average remaining contractual term (in years) of the non-employee options outstanding at December 31, 2013 and 2012 is 0.73 and 1.58, respectively.
The aggregate intrinsic value (defined as the excess of the market price of our common stock as of the end of the period over the exercise price of the related stock options) for all stock options (employee, Director and non-employee) outstanding and exercisable as of December 31, 2013 and 2012 was $0 for the respective periods.

Income_Taxes

Income Taxes	9 Months Ended	12 Months Ended
	Sep. 30, 2014	Dec. 31, 2013
Notes to Financial Statements	'	'
Income Taxes	'	'
	We have operated at a net loss since inception and have not recorded or paid any income taxes, other than for non-cash deferred tax expense related to a basis difference between financial reporting and tax reporting deductible goodwill. We have significant net operating loss (“NOL”) carry-forwards that would be recognized at such time as we demonstrate the ability to operate on a profitable basis for an extended period of time. The deferred income tax asset resulting primarily from the NOL carry-forwards has been fully reserved with a valuation allowance. Because goodwill is not depreciated and has an indefinite life for book purposes, the deferred tax liability related to the book to tax basis difference is not offset against the deferred tax assets when establishing our valuation allowance. Accordingly, we record non-cash deferred income tax expense, which increases the deferred tax liability, of approximately $16,000 each quarter.	Deferred income taxes reflect the net income tax effects of temporary differences between the amount of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes as well as income tax credit carry-forwards. The tax effects of temporary differences and credits that give rise to significant portions of the net deferred income tax asset are as follows:
			Year ended December 31,
			2013			2012
		NOL carry-forwards	$	18,439,000		$	17,729,000
		Book basis in goodwill in excess of tax basis		(723,000	)		(659,000	)
		Other intangible assets		277,000			392,000
		Non-cash stock-based compensation expense		4,402,000			4,401,000
		Non-deductible accruals		1,407,000			1,488,000
		Less: Valuation allowance		(24,525,000	)		(24,010,000	)
		Net deferred tax liability	$	(723,000	)	$	(659,000	)
		A valuation allowance must be established for a deferred income tax asset if it is more likely than not that a tax benefit may not be realized from the asset in the future. We have established a valuation allowance to the extent of our deferred income tax assets since it is not yet certain that absorption of the asset through future earnings will occur. Because goodwill is not depreciated and has an indefinite life for book purposes, the deferred tax liability related to the book to tax basis difference is not offset against the deferred tax assets when establishing our valuation allowance. Accordingly, we record non-cash deferred income tax expense, which increases the deferred tax liability, of approximately $65,000 each year.
		At December 31, 2013 and 2012, we had United States federal NOL carry-forwards available to offset future taxable income of approximately $46 and $44 million, respectively, which expire in the years 2013 through 2033. Under Section 382 of the Internal Revenue Code (“IRC”) of 1986, as amended, the utilization of United States NOL carry-forwards may be limited under the change in stock ownership rules of the IRC.
		We do not believe our equity raises and sale of common stock that we have completed triggered an ownership change. Furthermore, a limitation would not have an impact on our consolidated financial statements as we have recorded a valuation allowance for the entire amount of our deferred tax assets.
		The reconciliation of income tax computed at the United States federal statutory tax rate of 34% to the income tax benefit is as follows:
			Year ended December 31,
			2013			2012
		Tax benefit at federal statutory rate		-34	%		-34	%
		State taxes, net of federal income tax		-6	%		-6	%
		Change in deferred tax valuation allowance		35	%		37	%
		Income tax expense		-5	%		-3	%
		The effects of a tax position taken or expected to be taken in a tax return are to be recognized in the financial statements when it is more likely than not, based on the technical merits, that the position will be sustained upon examination. No uncertain tax positions have been identified through December 31, 2013 and 2012.

Equity_Commitment_and_Related_

Equity Commitment and Related Party Transactions	9 Months Ended
	Sep. 30, 2014
Notes to Financial Statements	'
Equity Commitment and Related Party Transactions	'
	Effective December 11, 2007, we received an investment commitment from Rex Carr, a Director of FPS and a holder of over 5% of our common stock. Pursuant to the terms of the commitment, Mr. Carr has agreed to invest up to an aggregate of $1,000,000 in FPS, at such time or times as we may request, in the form of a purchase or purchases of restricted common stock of FPS. FPS may elect to draw from the commitment at one time or from time to time; provided, however, that the aggregate of such draws may not exceed $1,000,000. If and when we elect to utilize available commitment funds, we will issue to Mr. Carr that number of shares of restricted common stock of FPS equal to the value of the investment then provided to FPS. The number of shares to be issued will be calculated based on the closing price of our common stock as quoted on OTC Market Group’s OTC Pink marketplace on the date of the sale. There is no stipulation regarding the duration of this commitment. As of September 30, 2014, $500,000 remains available under this equity commitment.
	As of December 31, 2013, the Company owed $500,000 to Mr. Carr. The terms of the loans associated with this cumulative loan balance did not require the payment of interest and did not require repayment of the principal by a certain date. On February 6, 2014, FPS issued 10,000,000 restricted shares of Company common stock in exchange for the cancellation of this note payable from a related party in the aggregate (face amount) of $500,000. This conversion of notes payable from a related party to restricted shares of the Company’s common stock was treated separately from the equity commitment in place with Mr. Carr.
	On February 4, 2013, David B. Norris, a Director of FPS, loaned us $50,000. The terms of this loan did not require the payment of interest and did not require repayment of the principal by a certain date. This loan was converted to 2,500,000 shares of the Company’s common stock on February 6, 2014.
	In conjunction with the conversion of Mr. Carr’s and Mr. Norris’ notes payable from a related party to equity, FPS recorded a $387,500 loss on the conversion of related party notes to our income statement during the nine months ended September 30, 2014.

Lease_Commitments

Lease Commitments	12 Months Ended
	Dec. 31, 2013
Notes to Financial Statements	'
Lease Commitments	'
	We entered into an operating lease for office space on January 1, 2002 that, as extended, now expires on April 30, 2017. Rent expense was $43,457 and $43,457 during the fiscal years ended December 31, 2013 and 2012, respectively. A 5-year office equipment lease entered into in 2005 expired in October 2010 and was replaced with a 4-year office equipment lease in November 2010.
	Future minimum lease payments as of December 31, 2013 are displayed below:
	Year ending December 31,
	2014	$	47,206
	2015	$	47,056
	2016	$	48,110
	2017	$	16,154
	2018	$	-
	Total minimum lease payments	$	158,526
	Future minimum lease payments as of December 31, 2012 are displayed below:
	Year ending December 31,
	2013	$	46,393
	2014	$	47,206
	2015	$	47,056
	2016	$	48,110
	2017	$	16,154
	2018	$	-
	Total minimum lease payments	$	204,919

Convertible_Note_Payable

Convertible Note Payable	9 Months Ended
	Sep. 30, 2014
Convertible Note Payable	'
Convertible Note Payable	'
	On August 22, 2014 (the “Closing Date”), FPS closed a financing transaction by entering into a Securities Purchase Agreement dated August 22, 2014 (the “Securities Purchase Agreement”) with certain funds and investors signatory to such Securities Purchase Agreement (the “Purchasers”) for an aggregate subscription amount of $1,000,000 (the “Purchase Price”). Pursuant to the Securities Purchase Agreement, FPS issued the following to the Purchasers: (i) 10% Convertible Promissory Notes with an aggregate principal amount of $1,150,000 (the “Notes”), and (ii) warrants to purchase an aggregate of 6,666,667 shares of the Company’s common stock, par value $0.01 per share, for an exercise price of $0.12 per share for a period of five (5) years from the effective date of the registration statement (the “Warrants”).
	The Company recorded $150,000 of original issuance cost related to this transaction, which we have recorded as debt discount.
	The terms of the Notes and the Warrants are as follows:
	10% Convertible Promissory Notes
	The total principal amount of the Notes is issued with a 115% premium to the subscription amount. The Notes accrue interest at a rate equal to 10% per annum and have a maturity date of February 22, 2016. The Notes are convertible any time after the issuance date of the Notes. The Purchasers have the right to convert the Notes into shares of the Company’s common stock at a conversion price equal to $0.10 per share, subject to standard adjustments for stock dividends, stock splits, subsequent equity sales, subsequent rights offerings and pro rata distributions. While the Notes are outstanding, in the event of a subsequent equity sale at a price lower than the conversion price of $0.10 per share, the conversion price of the Notes shall be reduced to the lower conversion price. The Notes can be redeemed under certain conditions and the Company can force the conversion of the Notes in the event certain equity conditions are met.
	In the event of default, the Purchasers have the right to require the Company to repay in cash all or a portion of the Notes at a price equal to 125% of the aggregate principal amount of the Notes plus all accrued but unpaid interest.
	Warrants
	The Warrants are exercisable in whole or in part, at an initial exercise price per share of $0.12, subject to adjustment. The exercise price and number of shares of the Company’s common stock issuable under the Warrants (the “Warrant Shares”) are subject to adjustments for stock dividends, splits, combinations, subsequent rights offerings, pro rata distributions and any issuance of securities below the exercise price of the Warrants. While the Warrants are outstanding, in the event of a subsequent equity sale including a warrant exercise price lower than the exercise price of $0.12 per share, the exercise price of the Warrants shall be reduced to the lower exercise price. Any adjustment to the exercise price shall similarly cause the number of Warrant Shares to be adjusted so that the total value of the Warrants may increase, provided, that in no event shall the number of Warrant Shares exceed 200% of the original number of Warrant Shares originally issued.
	In addition to the Warrants described above, the Company also issued 800,000 warrants to a placement agent assisting with the convertible note transaction. The terms of the placement agent warrants are the same as of the terms of the Warrants explained above.
	Registration Rights Agreement
	In connection with the sale of Notes and Warrants pursuant to the Securities Purchase Agreement, the Company entered into a registration rights agreement (the “Registration Rights Agreement”) with the Purchasers, pursuant to which the Company agreed to register all of the shares of common stock underlying the Notes and the shares of common stock underlying the Warrants (together, the “Registrable Securities”) on a Form S-1 registration statement (the “Registration Statement”) to be filed with the SEC within thirty (30) calendar days following the Closing Date (the “Filing Deadline”) and to use its best efforts to cause the Registration Statement to be declared effective under the Securities Act within 100 calendar days following the Closing Date (the “Effectiveness Deadline”). If the Company does not meet the Filing Deadline or the Effectiveness Deadline, the Company will have to pay the Purchasers a penalty equal to 1.5% of the aggregate subscription amount, up to a maximum penalty of 24%.
	FPS filed the Registration Statement with the SEC on September 19, 2014 and an amendment thereto on November 6, 2014.
	Deferred financing cost
	In connection with the convertible note transaction explained above, the Company paid $55,000 for legal fees and $80,000 for placement agent fees. In addition, $29,550 was also recorded to deferred financing costs related to the fair value valuation of the placement agent warrants. $10,877 of deferred financing costs was amortized during the third quarter of 2014. The deferred financing cost balance is $153,673 as of September 30, 2014.
	Derivative
	Because the above convertible debt and warrants have full reset adjustments tied to future issuances of equity securities by the Company, it is subject to derivative liability treatment under ASC 815-40-15, “Determining Whether an Instrument (or Embedded Feature) is Indexed to an Entity’s Own Stock” (“ASC 815-40-15”). ASC 815-40-15 requires as of the date the convertible debt and warrants are issued, the derivative liability to be measured at the fair value and re-evaluated at the end of each reporting period. See Note 8 – Derivative Liability.
	On issuance date the fair value of the derivative liability for both the convertible debt and warrants was $295,773 and $246,905, respectively. Therefore a total of $692,678 (including $150,000 original issuance costs) of debt discount was recorded. During the nine months ended September 30, 2014, $31,103 was recorded as amortization of debt discount. As of September 30, 2014, the convertible debt has a balance of $488,425, net of $661,575 of debt discount.

Blencathia_Merger

Blencathia Merger	9 Months Ended
	Sep. 30, 2014
Notes to Financial Statements	'
Blencathia Merger	'
	Effective October 27, 1999, we merged with Blencathia Acquisition Corporation (“Blencathia”). Blencathia was a public shell company with immaterial assets and liabilities and 312,000 shares outstanding at the time of the merger, which it redeemed and cancelled upon the merger. In exchange, we issued 312,000 of our common shares to the prior Blencathia owner with the contractual understanding that such shares were to be sold by that owner to achieve gross cash proceeds of $500,000. Any excess proceeds were to be returned to us and any deficiency was to be made up by us issuing additional shares or paying the difference in cash. As we believed that we controlled the ultimate timing of the sale of these 312,000 shares by the prior Blencathia owner, we did not consider these shares as issued or outstanding for purposes of computing earnings per share prior to 2006.
	In 2006, we learned that the prior Blencathia owner had, in fact, sold the 312,000 shares for aggregate proceeds of approximately $150,000, without our consent. Accordingly, in the fourth quarter of 2006, we recorded $500,000 of general expenses (representing the cost of the 1999 merger) and the deemed issuance of approximately $150,000 of common stock. The remaining $350,000 obligation was reflected as a current accrued expense. Beginning in 2006, the 312,000 shares have been reflected as outstanding for earnings per share computations. During 2009 and 2010, we made payments totaling $160,000 to the prior Blencathia owner. We have not made any payments to the prior Blencathia owner since 2010. The related current accrued expense balance remains at $190,000 at September 30, 2014. We are in negotiations with the prior Blencathia owner to resolve this obligation and may ultimately settle the obligation with either cash or equity securities with a lower market value.

Legal_Proceedings

Legal Proceedings	9 Months Ended	12 Months Ended
	Sep. 30, 2014	Dec. 31, 2013
Notes to Financial Statements	'	'
Legal Proceedings	'	'
	We are subject to various lawsuits and claims with respect to matters arising out of the normal course of business. While the impact on future financial results is not subject to reasonable estimation because considerable uncertainty exists, management believes, after consulting with counsel, that it is more likely than not that the ultimate liabilities resulting from such lawsuits and claims will not materially affect our financial position, results of operations or liquidity.	We are subject to various lawsuits and claims with respect to matters arising out of the normal course of business. While the impact on future financial results is not subject to reasonable estimation because considerable uncertainty exists, management believes, after consulting with counsel, that it is more likely than not that the ultimate liabilities resulting from such lawsuits and claims will not materially affect our financial position, results of operations or liquidity.
	On July 31, 2006, we received notice from the American Arbitration Association ("AAA") of a Demand for Arbitration dated July 27, 2006 received by the AAA naming FPS as Respondent and TPG Capital Partners (“TPG”), the prior Blencathia owner, as the Claimant. The arbitration had been requested by TPG to resolve an alleged aggregate proceeds shortfall from the sale of FPS securities issued in the Blencathia merger. TPG has claimed it sold some or all of the 312,000 shares and the sales have not generated at least $500,000 of proceeds, as guaranteed in the merger documents.	On July 31, 2006, we received notice from the American Arbitration Association (“AAA”) of a Demand for Arbitration dated July 27, 2006 received by the AAA naming the Company as Respondent and TPG Capital Partners (“TPG”), the prior Blencathia owner, as the Claimant. The arbitration had been requested by TPG to resolve an alleged aggregate proceeds shortfall from the sale of FPS securities issued in the Blencathia merger. TPG has claimed they sold some or all of the 312,000 shares and the sales have not generated at least $500,000 of proceeds, as guaranteed in the merger documents.
	In an effort to resolve this matter prior to submission to binding arbitration, both TPG and FPS participated in a non-binding mediation conference on January 30, 2007, which did not resolve the matter. Informal discussions are ongoing. It is not expected that the ultimate settlement of this matter, considering we have recorded a liability for the shortfall amount, will have an additional adverse material effect on FPS.	In an effort to resolve this matter prior to submission to binding arbitration, both TPG and the Company participated in a non-binding mediation conference on January 30, 2007, which did not resolve the matter. Informal discussions are ongoing. It is not expected that the ultimate settlement of this matter, considering we have recorded a liability for the shortfall amount, will have an additional adverse material effect on the Company. Since 2009, the Company has made payments to TPG totaling $160,000 to reduce the recorded liability. The remaining recorded liability balance is $190,000 at December 31, 2013 and 2012, respectively.

Derivative_Liability

Derivative Liability	9 Months Ended
	Sep. 30, 2014
Notes to Financial Statements	'
Derivative Liability	'
	During 2009, we granted a warrant to purchase 2,000,000 shares of the Company’s common stock to an accredited investor in conjunction with equity raise efforts. On April 12, 2013, the Company’s Board of Directors authorized and approved the extension of the expiration date and a change of exercise price for this warrant. The outstanding share purchase warrant originally had a March 23, 2014 expiration date and an exercise price of $0.25. The new modified terms extended the warrant expiration date to April 11, 2018 and reduced the exercise price to $0.226. The exercise price is also subject to dilutive adjustments for share issuances (full ratchet reset features). As of September 30, 2014, the exercise price has been reduced to $0.15 and an additional 1,321,583 warrants are to be issued to the investor due to the reset features.
	On August 22, 2014, we issued 6,666,667 warrants to investors and 800,000 warrants to a placement agent. The exercise price of these warrants is also subject to dilutive adjustments for share issuance (full ratchet reset features). See Note 6 – Convertible Note Payable.
	Because these convertible debt and warrants have full reset adjustments tied to future issuances of equity securities by the Company, it is subject to derivative liability treatment under ASC 815-40-15 , which requires as of the date the convertible debt and warrants are issued, the derivative liability to be measured at fair value and re-evaluated at the end of each reporting period.
	Key assumptions used to determine the fair value of the convertible note follows:
	Stock price volatility (one-year measurement):
	August 22, 2014 measurement		219	%
	September 30, 2014 measurement		211	%
	Probability of default triggering 21% interest rate, increasing 1% per month to a maximum of 10% with a 125% penalty		0	%
	Probability of the Company redeeming the convertible note (with 130% penalty)		0	%
	Conversion behavior - holder automatically converts the convertible note at a maximum of 2 times the conversion price
	Key assumptions used to determine the fair value of the warrants follows:
	Stock price volatility (one-year measurement):
	June 30, 2014 measurement		225	%
	August 22, 2014 measurement		219	%
	30-Sep-14		211	%
	Exercise behavior – warrant exercise at target prices 2 times the higher of the projected reset price or stock price
	As of December 31, 2013, we determined the fair value of the warrant’s derivative liability to be nominal.
	As of September 30, 2014, the fair value of the total convertible debt and warrant’s derivative liability is $639,637 and the Company recognized a loss on derivative liability of $67,409 for the nine months ended September 30, 2014. The following table summarizes the derivative liability included in the balance sheet:
	Balance at December 31, 2013	$	-
	Debt discount due to convertible note		295,773
	Debt discount due to warrant issued with debt		246,905
	Deferred financing cost due to derivative liability for placement agent warrant		29,550
	Loss on change of fair value		67,409
	Balance at September 30, 2014	$	639,637

Deferred_Revenue

Deferred Revenue	9 Months Ended	12 Months Ended
	Sep. 30, 2014	Dec. 31, 2013
Notes to Financial Statements	'	'
Deferred Revenue	'	'
	On February 26, 2009, we received the first purchase order pursuant to a Memorandum of Understanding (“MOU”) with Libya Oil Holdings Limited, Tamoil, Libya Africa Investment Portfolio and Vision Oil Services Ltd (“VOS”). Pursuant to the MOU, VOS paid for the purchase of 600 metric tons of DiesoLiFTTM 10 at a price of 6,000 Euros (approximately $7,600) per metric ton from FPS. We received cash proceeds of approximately $3 million from VOS in February 2009. No such revenues had been recorded to date relating to this order because there has been no requested delivery of the product. We have had no communication with VOS in nearly five years and believe they have ceased all activities on behalf of FPS.	On February 26, 2009, we received the first purchase order pursuant to a Memorandum of Understanding (“MOU”) with Libya Oil Holdings Limited, Tamoil, Libya Africa Investment Portfolio and Vision Oil Services Ltd (“VOS”). Pursuant to the MOU, VOS paid for the purchase of 600 metric tons of DiesoLiFTTM 10 at a price of 6,000 Euros (approximately $7,600) per metric ton from IFT. We received cash proceeds of approximately $3 million from VOS in February 2009. No such revenues have been recorded to date relating to this order because there has been no requested delivery of the product. We have had no communication with VOS in nearly 5 years and believe they have ceased all activities on behalf of FPS.
	Based upon a written legal opinion received during the first quarter of 2014, it was determined that effective February 2014, we were no longer obligated to present the nearly $3 million deferred revenue liability on our balance sheet as the statute of limitations period for our performance obligation has passed. In conjunction with this determination, we recorded a gain on deferred revenue liability write off of approximately $3 million during the nine months ended September 30, 2014.	Effective February 2014, based upon a legal opinion received during the first quarter of 2014, we will no longer present the nearly $3 million deferred revenue liability on our balance sheet as the statute of limitations period for our performance obligation has passed.

Notes_Payable_Related_Parties

Notes Payable - Related Parties	12 Months Ended
	Dec. 31, 2013
Notes to Financial Statements	'
Notes Payable - Related Parties	'
	During 2013 and 2012, the Company borrowed money from certain related parties for operations.
	In 2013 and 2012, the advances from the related parties are $450,000 and $260,000, respectively. Payments made to the related parties were $100,000 and $0 in 2013 and 2012, respectively.
	During 2012, related parties converted a total of $60,000 of debt into 600,000 shares of common stock.
	As of December 31, 2013 and 2012, the Company owed $550,000 and $200,000 to these related parties.
	The notes are due on demand and bear a 0% interest rate.

Accounts_Payable

Accounts Payable	9 Months Ended
	Sep. 30, 2014
Accounts Payable	'
Accounts Payable	'
	As of September 30, 2014, we recognized a $59,899 gain on write off of accounts payable. The invoice and contracts for the total of $59,889 were dated at least five years before September 30, 2014. Based on a written legal opinion received during the third quarter of 2014, it was determined that effective September 30, 2014, we were no longer obligated to present the $59,889 of accounts payable on our balance sheet as the statute of limitation period for our payment obligation has passed. In conjunction with this determination, we recorded a gain on accounts payable write off of $59,889 during the nine months ended September 30, 2014.

Subsequent_Events

Subsequent Events	12 Months Ended
	Dec. 31, 2013
Notes to Financial Statements	'
Subsequent Events	'
	Subsequent to December 31, 2013 we sold a total of 31,645,558 to accredited investors which yielded aggregate proceeds of $812,777.
	On February 6, 2014, in exchange for the cancellation of $550,000 of notes payable from related parties, we issued a cumulative total of 12,500,000 restricted shares. The fair value of the shares was calculated based on the respective date of issuance. The terms of these loans did not require the payment of interest, and did not require repayment of the principal by a certain date. No principal or interest relating to the cancelled loan was paid by FPS.
	Effective February 2014, based upon a legal opinion received during the first quarter of 2014, we will no longer present the nearly $3 million deferred revenue liability on our balance sheet as the statute of limitations period for our performance obligation has passed.
	During the first quarter of 2014, the Company and the Board authorized the issuance of 15,526,000 options to employees and Directors of the Company. The primary purpose of these option grants were to replace options that had recently expired and/or that would be expiring during 2014. The options have an exercise price of $0.05, vest solely at the discretion of the Company’s Chief Executive Officer and expire on January 31, 2019.

Nature_of_Business_and_Signifi1

Nature of Business and Significant Accounting Policies (Policies)	9 Months Ended									12 Months Ended
	Sep. 30, 2014									Dec. 31, 2013
Nature Of Business And Significant Accounting Policies Policies	'									'
Derivative Financial Instruments	'									'
	The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in our statements of operations. For stock-based derivative financial instruments, the Company uses a Lattice Model option pricing model, in accordance with the Financial Accounting Standards Board (the “FASB”) Accounting Standards Codification (“ASC”) ASC 815-15, “Derivatives and Hedging,” to value the derivative instruments at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in our balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date.
Nature of Business	'									'
										Fuel Performance Solutions, Inc. (“FPS,” “we” or the “Company”) is a company that was incorporated under the laws of the State of Nevada on April 9, 1996. On February 5, 2014, the Company changed its name from International Fuel Technology, Inc. to Fuel Performance Solutions, Inc. We have developed a family of fuel additive product formulations. These unique fuel blends have been created to improve fuel economy, enhance lubricity (reducing engine wear and tear) and lower harmful engine emissions, while decreasing reliance on petroleum-based fuels through the use of more efficient, alternative and renewable fuels. We began transitioning from a development stage technology company to a commercial entity during 2002 and have been increasing our product marketing and sales efforts since. We are now focused on continuing to develop the body of evidence of the efficacy of our products applicable to a wide range of markets and industries within these markets through additional industry specific laboratory testing and customer field-based demonstration trials. In addition, we are continuing to strengthen our distributor and customer contact base. Marketing and sales efforts, in conjunction with the additional industry specific testing, will complete our transition to a commercial enterprise.
										During 2013, our net revenues were split in the following manner: 9% to United States end-user customers and 91% to international distributors and end-user customers. 92% of our net revenues for 2013 were concentrated among 5 customers.
										During 2012, our net revenues were split in the following manner: 17% to United States end-user customers and 83% to international distributors and end-user customers. 90% of our net revenues for 2012 were concentrated among 3 customers.
										At December 31, 2012, 95% of our accounts receivable balance was attributable to 1 customer.
										Customers whose revenues exceeded 10% of our total revenues for 2013 and 2012, respectively, are listed below:
										Customer Name	2013			2012
										Nordmann, Rassmann		74	%		59	%
										Schnucks Markets, Inc.		*			14	%
										Next Group Brazil		12	%		-
										East Midlands Trains Limited		-			17	%
										*Below 10% threshold for applicable period
										Our product line revenues for 2013 and 2012 have not been significant. See the table below for a breakdown of our product line revenues:
											2013						2012
										FPS Product	$				%		$		%
										DiesoLiFTTM 10	$	55,763			8	%	$	107,210	32	%
										PerfoLiFT BD-Series		633,931			90	%		209,394	62	%
										Other		14,495			2	%		18,492	6	%
										Total revenues	$	704,189			100	%	$	335,096	100	%
										Net revenues related to shipments into various foreign countries were $640,004 and $279,470  during 2013 and 2012, respectively. The following table breaks out net revenues by foreign country:
										Country	2013			2012
										Brazil	$	88,361		$	-
										China		-			-
										Czech. Republic		139,640			63,513
										Cyprus		12,175			5,028
										France		14,495			18,492
										Germany		310,649			135,357
										Romania		68,631			-
										United Kingdom		6,053			57,080
											$	640,004		$	279,470
										We currently utilize Brenntag as our contracted product manufacturer. Brenntag independently purchases required raw materials to manufacture our product. For the years ended December 31, 2013 and 2012, 100% of our product manufacturing has been handled by Brenntag.
Use of Estimates in the Preparation of Financial Statements	'									'
										The preparation of financial statements in conformity with United States generally accepted accounting principles (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Reclassifications	'									'
										Certain prior year amounts have been reclassified to conform to the current year presentation.
Concentration of Credit Risk	'									'
										Financial instruments which potentially subject the Company to concentrations of credit risk consist of cash and trade receivables. The Company places its cash with high credit quality financial institutions. At times such cash may be in excess of the FDIC limit. With respect to trade receivables, the Company routinely assesses the financial strength of its customers and, as a consequence, believes that the receivable credit risk exposure is limited.
Related Parties	'									'
										A party is considered to be related to the Company if the party directly or indirectly or through one or more intermediaries, controls, is controlled by, or is under common control with the Company. Related parties also include principal owners of the Company, its management, members of the immediate families of principal owners of the Company and its management and other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests. A party which can significantly influence the management or operating policies of the transacting parties or if it has an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests is also a related party.
Revenue Recognition	'									'
										We recognize revenue from the sale of our products when the price is fixed and determinable, persuasive evidence of an arrangement exists, the products are shipped, and title and risk of loss has passed to the buyer and collectability of the resulting receivable is reasonably assured. A majority of our revenues is from sales to product distributors. Product distributors do not have the option to return product that is not immediately sold to an end-user. Therefore, our revenue recognition is not conditional on whether a distributor is able to sell product to an ultimate product end-user. Our sales policies for end-users are consistent with product distributor sales policies.
										Beginning in May 2013, as an effort to address our outstanding payable balance with and at the request of our product manufacturer, our non-United States customers began remitting receivable payments directly to our product manufacturer in lieu of remitting payment directly to us. Under this arrangement, we still maintained the risks and benefits related to sending the product to each customer and thus recorded sales revenues (and associated cost of sales) applying the gross reporting treatment for each transaction pursuant to ASC 605-45, “Principal Agent Considerations.”
Cash and Cash Equivalents	'									'
										Cash and cash equivalents include cash on hand and temporary investments with a maturity of three months or less. We maintain cash in a bank account, which, at times, exceeds federally insured limits. We have experienced no losses relating to these excess amounts of cash in a bank.
										We utilize a cash management program that assesses daily cash requirements. Excess funds are invested in overnight repurchase agreements backed by United States Treasury securities. Repurchase agreements are not deposits, are not insured or guaranteed by the United States government, the Federal Deposit Insurance Corporation or any other government agency, and involve investment risk including possible loss of principal.
Accounts Receivable	'									'
										An allowance for doubtful accounts is maintained at a level we believe sufficient to cover potential losses based on historical trends and known current factors impacting our customers. We have determined that an allowance for doubtful accounts was not necessary as of December 31, 2013 and 2012.
Inventory	'									'
										Inventory, which consists of finished product, is valued at the lower of cost or market, based on the first-in, first-out (“FIFO”) method, or market, and reflects the purchased cost from vendors. Although we maintain minimal inventory levels in the United States at external storage facilities, the majority of our inventory is manufactured based on customer demand and immediately shipped to customers upon completion. The raw material components required to manufacture our products reside at our product manufacturer’s facilities.
Goodwill	'									'
										The Company accounts for goodwill and intangible assets in accordance with ASC 350 "Intangibles-Goodwill and Other" ("ASC 350"). ASC 350 requires that goodwill and other intangibles with indefinite lives be tested for impairment annually or on an interim basis if events or circumstances indicate that the fair value of an asset has decreased below its carrying value. In addition, ASC 350 requires that goodwill be tested for impairment at the reporting unit level (operating segment or one level below an operating segment) on an annual basis and between annual tests when circumstances indicate that the recoverability of the carrying amount of goodwill may be in doubt. Application of the goodwill impairment test requires judgment, including the identification of reporting units; assigning assets and liabilities to reporting units, assigning goodwill to reporting units, and determining the fair value. Significant judgments required to estimate the fair value of reporting units include estimating future cash flows, determining appropriate discount rates and other assumptions. Changes in these estimates and assumptions or the occurrence of one or more confirming events in future periods could cause the actual results or outcomes to materially differ from such estimates and could also affect the determination of fair value and/or goodwill impairment at future reporting dates.
										The Company completed an evaluation of goodwill at December 31, 2013 and 2012 and determined that there was no impairment. The Company employed a qualitative evaluation for 2013 analysis. For the 2012 evaluation, a net book value of less than $0 was determined using the Step 1 test. The Company determined that its qualitative evaluation for 2012 resulted in a less than more likely than not determination of impairment, resulting in the Step 2 test being bypassed.
Income Taxes	'									'
										The Company accounts for income taxes utilizing ASC 740, “Income Taxes” (“ASC 740”). ASC 740 requires the measurement of deferred tax assets for deductible temporary differences and operating loss carry forwards, and of deferred tax liabilities for taxable temporary differences. Measurement of current and deferred tax liabilities and assets is based on provisions of enacted tax law. The effects of future changes in tax laws or rates are not included in the measurement. The Company recognizes the amount of taxes payable or refundable for the current year and recognizes deferred tax liabilities and assets for the expected future tax consequences of events and transactions that have been recognized in the Company’s financial statements or tax returns. The Company currently has substantial NOL carry forwards. The Company has recorded a 100% valuation allowance against net deferred tax assets due to uncertainty of their ultimate realization. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized.
Research and Development	'									'
										Research and development costs are expensed as incurred. Expense for services received from external vendors for 2013 and 2012 was $80,689 and $96,117, respectively.
Advertising Expenses	'									'
										Advertising costs are expensed as incurred and amounted to $56,219 and $73,772 in 2013 and 2012, respectively.
Basic and Diluted Net Earnings (Loss) Per Common Share	'									'
										The Company accounts for earnings per share pursuant to ASC 260, “Earnings per Share,” which requires disclosure on the financial statements of "basic" and "diluted" earnings (loss) per share. Basic earnings (loss) per share are computed by dividing net income (loss) by the weighted average number of common shares outstanding for the year. Diluted earnings (loss) per share is computed by dividing net income (loss) by the weighted average number of common shares outstanding plus common stock equivalents (if dilutive) related to stock options and warrants for each year. As there was a net loss for the periods, basic and diluted loss per share is the same for the years ended December 31, 2013 and 2012, respectively.
Fair Value of Financial Instruments	'									'
	The Company measures its financial assets and liabilities in accordance with the requirements of ASC 820, “Fair Value Measurements and Disclosures.” ASC 820 clarifies the definition of fair value, prescribes methods for measuring fair value, and establishes a fair value hierarchy to classify the inputs used in measuring fair value as follows:									The Company measures its financial assets and liabilities in accordance with the requirements of ASC 820, “Fair Value Measurements and Disclosures” (“ASC 820”). ASC 820 clarifies the definition of fair value, prescribes methods for measuring fair value, and establishes a fair value hierarchy to classify the inputs used in measuring fair value as follows:
	Level 1 - Quoted prices are available in active markets for identical assets or liabilities as of the reporting date. Active markets are those in which transactions for the asset or liability occur in sufficient frequency and volume to provide pricing information on an ongoing basis. Level 1 primarily consists of financial instruments such as exchange-traded derivatives, marketable securities and listed equities.									Level 1 – Quoted prices are available in active markets for identical assets or liabilities as of the reporting date. Active markets are those in which transactions for the asset or liability occur in sufficient frequency and volume to provide pricing information on an ongoing basis. Level 1 primarily consists of financial instruments such as exchange-traded derivatives, marketable securities and listed equities.
	Level 2 - Pricing inputs are other than quoted prices in active markets included in level 1, which are either directly or indirectly observable as of the reported date and includes those financial instruments that are valued using models or other valuation methodologies. These models are primarily industry-standard models that consider various assumptions, including quoted forward prices for commodities, time value, volatility factors, and current market and contractual prices for the underlying instruments, as well as other relevant economic measures. Substantially all of these assumptions are observable in the marketplace throughout the full term of the instrument, can be derived from observable data or are supported by observable levels at which transactions are executed in the marketplace. Instruments in this category generally include non-exchange-traded derivatives such as commodity swaps, interest rate swaps, options and collars.									Level 2 - Pricing inputs are other than quoted prices in active markets included in level 1, which are either directly or indirectly observable as of the reported date and includes those financial instruments that are valued using models or other valuation methodologies. These models are primarily industry-standard models that consider various assumptions, including quoted forward prices for commodities, time value, volatility factors, and current market and contractual prices for the underlying instruments, as well as other relevant economic measures. Substantially all of these assumptions are observable in the marketplace throughout the full term of the instrument, can be derived from observable data or are supported by observable levels at which transactions are executed in the marketplace. Instruments in this category generally include non-exchange-traded derivatives such as commodity swaps, interest rate swaps, options and collars.
	Level 3 - Pricing inputs include significant inputs that are generally less observable from objective sources. These inputs may be used with internally developed methodologies that result in management’s best estimate of fair value.									Level 3 – Pricing inputs include significant inputs that are generally less observable from objective sources. These inputs may be used with internally developed methodologies that result in management’s best estimate of fair value.
	The following table sets forth by level within the fair value hierarchy the Company’s financial assets and liabilities that were accounted for at fair value as of September 30, 2014, and December 31, 2013:
	Recurring Fair Value Measures	Level 1		Level 2		Level 3		Total
	30-Sep-14
	Derivative liability	$	-	$	-	$	639,637	$	639,637
	31-Dec-13
	Derivative liability	$	-	$	-	$	-	$	-
Employee Stock-Based Compensation	'									'
										The Company accounts for stock-based compensation in accordance with ASC 718, “Compensation-Stock Compensation” (“ASC 718). ASC 718 requires companies to measure the cost of employee services received in exchange for an award of equity instruments, including stock options, based on the grant date fair value of the award and to recognize it as compensation expense over the period the employee is required to provide service in exchange for the award, usually the vesting period.
Non-Employee Stock-Based Compensation	'									'
										The Company accounts for stock-based compensation in accordance with the provision of ASC 505, “Equity Based Payments to Non-Employees” (“ASC 505”), which requires that such equity instruments are recorded at their fair value on the measurement date. The measurement of stock-based compensation is subject to periodic adjustment as the underlying equity instruments vest.
Recently Issued Accounting Pronouncements	'									'
										Management does not believe that any recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company's financial statements.

Nature_of_Business_and_Signifi2

Nature of Business and Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2013
Nature Of Business And Significant Accounting Policies Tables	'
Schedules of Concentration of Revenue	'
	Customers whose revenues exceeded 10% of our total revenues for 2013 and 2012, respectively, are listed below:
	Customer Name	2013			2012
	Nordmann, Rassmann		74	%		59	%
	Schnucks Markets, Inc.		*			14	%
	Next Group Brazil		12	%		-
	East Midlands Trains Limited		-			17	%
	*Below 10% threshold for applicable period
	Our product line revenues for 2013 and 2012 have not been significant. See the table below for a breakdown of our product line revenues:
		2013						2012
	FPS Product	$				%		$		%
	DiesoLiFTTM 10	$	55,763			8	%	$	107,210	32	%
	PerfoLiFT BD-Series		633,931			90	%		209,394	62	%
	Other		14,495			2	%		18,492	6	%
	Total revenues	$	704,189			100	%	$	335,096	100	%
	Net revenues related to shipments into various foreign countries were $640,004 and $279,470  during 2013 and 2012, respectively. The following table breaks out net revenues by foreign country:
	Country	2013			2012
	Brazil	$	88,361		$	-
	China		-			-
	Czech. Republic		139,640			63,513
	Cyprus		12,175			5,028
	France		14,495			18,492
	Germany		310,649			135,357
	Romania		68,631			-
	United Kingdom		6,053			57,080
		$	640,004		$	279,470

Significant_Accounting_Policie1

Significant Accounting Policies (Tables)	9 Months Ended
	Sep. 30, 2014
Significant Accounting Policies Tables	'
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis	'
	The following table sets forth by level within the fair value hierarchy the Company’s financial assets and liabilities that were accounted for at fair value as of September 30, 2014, and December 31, 2013:
	Recurring Fair Value Measures	Level 1		Level 2		Level 3		Total
	30-Sep-14
	Derivative liability	$	-	$	-	$	639,637	$	639,637
	31-Dec-13
	Derivative liability	$	-	$	-	$	-	$	-

Stockholders_Deficit_Tables

Stockholders' Deficit (Tables)	9 Months Ended										12 Months Ended
	Sep. 30, 2014										Dec. 31, 2013
Stockholders Deficit Tables	'										'
Schedule of Warrants Issued	'										'
											Year Warrants Issued	No. of Warrants Issued			Warrant Exercise Price		Warrant Expiration Date
											2009		4,325,000		$	0.25		2014
											2011		2,570,750		$	0.25		2016
											2011		250,000		$	0.25		2013
											2012		9,825,000		$	0.1		2017
											2013		4,875,000		$	0.1		2018
Schedule of Information related to Warrants	'										'
											Further information relating to warrants is as follows:
															Weighted-		Weighted-
												Number			Average		Average
												of			Exercise		Exercise
												Shares			Price		Life
											Outstanding at December 31, 2011		7,145,750		$	0.25		3.04
											Granted		9,825,000		$	0.1		4.66
											Outstanding at December 31, 2012		16,970,750		$	0.16		3.55
											Granted		4,875,000		$	0.1		4.26
											Expired		(250,000	)	$	0.25		-
											Outstanding at December 31, 2013		21,595,750		$	0.15		3.35
Schedule of Stock Option Recorded	'										'
	Non-cash stock-based compensation expense recorded in the three and nine months ended September 30, 2014 and September 30, 2013 is as follows:
		Three Months Ended			Three Months Ended		Nine Months Ended		Nine Months Ended
		September 30,			September 30,		September 30,		September 30,
		2014			2013		2014		2013
	Awards to employees	$	71,191		$	-	$	2,355,669	$	-
	Awards to non-employees		-			-		83,314		16,875
	Total non-cash stock-based compensation expense	$	71,191		$	-	$	2,438,983	$	16,875
Schedule of Stock Option Issued to Employees and Directors	'										'
	The following tables summarize information about stock options issued to employees and Directors during the nine months ended September 30, 2014:
		Shares			Weighted-average exercise price		Weighted-average exercise life		Intrinsic value
	Outstanding at December 31, 2013		9,489,120		$	0.41		1.06	$	-
	Granted		30,026,000		$	0.1		4.49
	Cancelled		(7,070,400	)	$	0.39		-
	Expired		(120,000	)	$	0.25		-
	Outstanding at September 30, 2014		32,324,720		$	0.13		4.19	$	671,031
	Options exercisable at September 30, 2014		28,991,386		$	0.13		4.16
	Options exercisable at December 31, 2013		9,489,120		$	0.41		1.06
Schedule of primary assumptions used to value employee and Director non-cash stock-based compensation	'										'
	The following table provides the primary assumptions used to value employee and Director non-cash stock-based compensation for the nine months ended September 30, 2014:
		For the Nine Months Ended September 30, 2014
	Weighted-average fair value of options granted	$	0.09
	Weighted-average assumptions:
	Risk-free interest rate		0.65	%
	Dividend yield		-
	Expected volatility		1.09
	Expected option life (years)		2.58
Schedule of Stock Option Issued to non employees	'										'
	The following table summarizes information about stock options issued to non-employees during the nine months ended September 30, 2014:
		Shares			Weighted-average exercise price		Weighted-average exercise life		Intrinsic value
	Outstanding at December 31, 2013		4,137,599		$	0.46		0.73	$	-
	Granted		1,555,000		$	0.08		2.99
	Cancelled		(1,352,000	)	$	0.48		-
	Expired		(2,015,600	)	$	0.47		-
	Outstanding at September 30, 2014		2,324,999		$	0.19		2.26	$	24,500
	Options exercisable at September 30, 2014		2,324,999		$	0.19		2.26
	Options exercisable at December 31, 2013		4,132,399		$	0.46		0.73

Stock_Options_Tables

Stock Options (Tables)	9 Months Ended										12 Months Ended
	Sep. 30, 2014										Dec. 31, 2013
											Stock Option
Schedule of Stock Option Issued to Employees and Directors	'										'
	The following tables summarize information about stock options issued to employees and Directors during the nine months ended September 30, 2014:										The following tables summarize information about stock options issued to employees and Directors during the 2 years ended December 31, 2013:
		Shares			Weighted-average exercise price		Weighted-average exercise life		Intrinsic value				Shares				Exercise price per share			Weighted-average exercise price
	Outstanding at December 31, 2013		9,489,120		$	0.41		1.06	$	-	Outstanding at December 31, 2011			11,993,120			$	0.10-0.96		$	0.43
	Granted		30,026,000		$	0.1		4.49			Granted			50,000			$	0.09		$	0.09
	Cancelled		(7,070,400	)	$	0.39		-			Expired			(546,000	)		$	0.15-0.72		$	0.52
	Expired		(120,000	)	$	0.25		-			Outstanding at December 31, 2012			11,497,120			$	0.09-0.96		$	0.43
	Outstanding at September 30, 2014		32,324,720		$	0.13		4.19	$	671,031
											Expired			(2,008,000	)		$	0.21-0.96		$	0.53
	Options exercisable at September 30, 2014		28,991,386		$	0.13		4.16
	Options exercisable at December 31, 2013		9,489,120		$	0.41		1.06			Outstanding at December 31, 2013			9,489,120			$	0.09-0.50		$	0.41
											Options exercisable at December 31, 2013			9,489,120			$	0.09-0.50		$	0.41
											Options exercisable at December 31, 2012			11,497,120			$	0.09-0.96		$	0.43
Schedule of Employee Stock Option Outstanding	'										'
											The following table summarizes information about employee stock options outstanding at December 31, 2013:
														Options Outstanding									Options Exercisable
														Number outstanding at				Weighted-average remaining			Weighted-average		Number exercisable at		Weighted-average
											Exercise price range			31-Dec-13				contractual life (years)			exercise price		31-Dec-13		exercise price
											$0.09 - $0.25				2,435,760				1		$	0.2		2,435,760	$	0.2
											$0.26 - $0.50				7,053,360				1		$	0.48		7,053,360	$	0.48
															9,489,120				1		$	0.41		9,489,120	$	0.41
											The following table summarizes information about employee stock options outstanding at December 31, 2012:
														Options Outstanding									Options Exercisable
														Number outstanding at				Weighted-average remaining			Weighted-average		Number exercisable at		Weighted-average
											Exercise price range			31-Dec-12				contractual life (years)			exercise price		31-Dec-12		exercise price
											$0.09 - $0.50				11,341,120				2		$	0.42		11,341,120	$	0.42
											$0.51 - $1.00				156,000				1		$	0.96		156,000	$	0.96
															11,497,120				2		$	0.43		11,497,120	$	0.43
Schedule of Stock Option Issued to non employees	'										'
	The following table summarizes information about stock options issued to non-employees during the nine months ended September 30, 2014:										The following table summarizes information about stock options issued to non-employees during the 2 years ended December 31, 2013:
		Shares			Weighted-average exercise price		Weighted-average exercise life		Intrinsic value								Exercise price per share			Weighted-average exercise price
													Shares
	Outstanding at December 31, 2013		4,137,599		$	0.46		0.73	$	-
											Outstanding at December 31, 2011			4,785,599			$	0.25-0.96		$	0.49
	Granted		1,555,000		$	0.08		2.99
	Cancelled		(1,352,000	)	$	0.48		-			Granted			150,000			$	0.25		$	0.25
	Expired		(2,015,600	)	$	0.47		-			Expired			(154,000	)		$	0.29-0.38		$	0.32
	Outstanding at September 30, 2014		2,324,999		$	0.19		2.26	$	24,500	Outstanding at December 31, 2012			4,781,599			$	0.25-0.96		$	0.49
	Options exercisable at September 30, 2014		2,324,999		$	0.19		2.26			Expired			(644,000	)		$	0.25-0.96		$	0.57
	Options exercisable at December 31, 2013		4,132,399		$	0.46		0.73			Outstanding at December 31, 2013			4,137,599			$	0.25-0.50		$	0.46
											Options exercisable at December 31, 2013			4,132,399			$	0.25-0.50		$	0.46
											Options exercisable at December 31, 2012			4,776,399			$	0.25-0.96		$	0.49
Schedule of Stock Option Recorded	'										'
	Non-cash stock-based compensation expense recorded in the three and nine months ended September 30, 2014 and September 30, 2013 is as follows:										Stock option expense recorded in 2013 and 2012 is as follows:
		Three Months Ended			Three Months Ended		Nine Months Ended		Nine Months Ended				Year Ended December 31, 2013				Year Ended December 31, 2012
		September 30,			September 30,		September 30,		September 30,		Awards to employees/Directors		$	-			$	3,396
		2014			2013		2014		2013		Awards to non-employees			-				11,457
											Stock option modifications			-				-
	Awards to employees	$	71,191		$	-	$	2,355,669	$	-	Total non-cash stock-based compensation expense		$	-			$	14,853
	Awards to non-employees		-			-		83,314		16,875
	Total non-cash stock-based compensation expense	$	71,191		$	-	$	2,438,983	$	16,875
Schedule of primary assumptions used to value employee and Director non-cash stock-based compensation	'										'
	The following table provides the primary assumptions used to value employee and Director non-cash stock-based compensation for the nine months ended September 30, 2014:										The following table provides the primary assumptions used to value employee and Director non-cash stock-based compensation for the years indicated:
		For the Nine Months Ended September 30, 2014										Year Ended		Year Ended
												31-Dec-13		31-Dec-12
	Weighted-average fair value of options granted	$	0.09
	Weighted-average assumptions:										Weighted-average fair value of options granted	NA		$	0.07
	Risk-free interest rate		0.65	%							Weighted-average assumptions:
	Dividend yield		-								Risk-free interest rate	NA			0.74	%
	Expected volatility		1.09								Dividend yield	NA			-
	Expected option life (years)		2.58								Expected volatility	NA			1.03
											Expected option life (years)	NA			5

Income_Taxes_Tables

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2013
Income Taxes Tables	'
Schedule of temporary differences and credits that give rise to significant portions of net deferred income tax asset	'
	Deferred income taxes reflect the net income tax effects of temporary differences between the amount of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes as well as income tax credit carry-forwards. The tax effects of temporary differences and credits that give rise to significant portions of the net deferred income tax asset are as follows:
		Year ended December 31,
		2013			2012
	NOL carry-forwards	$	18,439,000		$	17,729,000
	Book basis in goodwill in excess of tax basis		(723,000	)		(659,000	)
	Other intangible assets		277,000			392,000
	Non-cash stock-based compensation expense		4,402,000			4,401,000
	Non-deductible accruals		1,407,000			1,488,000
	Less: Valuation allowance		(24,525,000	)		(24,010,000	)
	Net deferred tax liability	$	(723,000	)	$	(659,000	)
Schedule of effective income tax rate reconciliation	'
	The reconciliation of income tax computed at the United States federal statutory tax rate of 34% to the income tax benefit is as follows:
		Year ended December 31,
		2013			2012
	Tax benefit at federal statutory rate		-34	%		-34	%
	State taxes, net of federal income tax		-6	%		-6	%
	Change in deferred tax valuation allowance		35	%		37	%
	Income tax expense		-5	%		-3	%

Lease_Commitments_Tables

Lease Commitments (Tables)	12 Months Ended
	Dec. 31, 2013
Lease Commitments Tables	'
Schedule of Minimum Future Lease Payment	'
	Future minimum lease payments as of December 31, 2013 are displayed below:
	Year ending December 31,
	2014	$	47,206
	2015	$	47,056
	2016	$	48,110
	2017	$	16,154
	2018	$	-
	Total minimum lease payments	$	158,526
	Future minimum lease payments as of December 31, 2012 are displayed below:
	Year ending December 31,
	2013	$	46,393
	2014	$	47,206
	2015	$	47,056
	2016	$	48,110
	2017	$	16,154
	2018	$	-
	Total minimum lease payments	$	204,919

Derivative_Liability_Tables

Derivative Liability (Tables)	9 Months Ended
	Sep. 30, 2014
Derivative Liability Tables	'
Fair value of convertible note	'
	Key assumptions used to determine the fair value of the convertible note follows:
	Stock price volatility (one-year measurement):
	August 22, 2014 measurement		219	%
	September 30, 2014 measurement		211	%
	Probability of default triggering 21% interest rate, increasing 1% per month to a maximum of 10% with a 125% penalty		0	%
	Probability of the Company redeeming the convertible note (with 130% penalty)		0	%
	Conversion behavior - holder automatically converts the convertible note at a maximum of 2 times the conversion price
	Key assumptions used to determine the fair value of the warrants follows:
	Stock price volatility (one-year measurement):
	June 30, 2014 measurement		225	%
	August 22, 2014 measurement		219	%
	30-Sep-14		211	%
	Exercise behavior – warrant exercise at target prices 2 times the higher of the projected reset price or stock price
Summary of derivative liability	'
	The following table summarizes the derivative liability included in the balance sheet:
	Balance at December 31, 2013	$	-
	Debt discount due to convertible note		295,773
	Debt discount due to warrant issued with debt		246,905
	Deferred financing cost due to derivative liability for placement agent warrant		29,550
	Loss on change of fair value		67,409
	Balance at September 30, 2014	$	639,637

Nature_of_Business_and_Signifi3

Nature of Business and Significant Accounting Policies (Details) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Concentration Risk, Percentage	100.00%	100.00%
Revenue	$704,189	$335,096
Nordmann, Rassmann [Member]	'	'
Concentration Risk, Percentage	74.00%	59.00%
Next Group Brazil [Member]	'	'
Concentration Risk, Percentage	12.00%	'
Schnucks Markets, Inc [Member]	'	'
Concentration Risk, Percentage	'	14.00%
East Midlands Trains Limited [Member]	'	'
Concentration Risk, Percentage	'	17.00%
DiesoLiFT 10 [Member]	'	'
Concentration Risk, Percentage	8.00%	32.00%
Revenue	55,763	107,210
PerfoLiFT BD-Series [Member]	'	'
Concentration Risk, Percentage	90.00%	62.00%
Revenue	633,931	209,394
Other [Member]	'	'
Concentration Risk, Percentage	2.00%	6.00%
Revenue	$14,495	$18,492

Nature_of_Business_and_Signifi4

Nature of Business and Significant Accounting Policies (Details 1) (USD $)	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013	Dec. 31, 2013	Dec. 31, 2012
Net revenues	$677,105	$59,463	$1,506,198	$384,289	$704,189	$335,096
Brazil	'	'	'	'	'	'
Net revenues	'	'	'	'	88,361	'
Czech. Republic	'	'	'	'	'	'
Net revenues	'	'	'	'	139,640	63,513
Cyprus	'	'	'	'	'	'
Net revenues	'	'	'	'	12,175	5,028
France	'	'	'	'	'	'
Net revenues	'	'	'	'	14,495	18,492
Germany	'	'	'	'	'	'
Net revenues	'	'	'	'	310,649	135,357
United Kingdom	'	'	'	'	'	'
Net revenues	'	'	'	'	6,053	57,080
Romania	'	'	'	'	'	'
Net revenues	'	'	'	'	68,631	'
China	'	'	'	'	'	'
Net revenues	'	'	'	'	'	'

Nature_of_Business_and_Signifi5

Nature of Business and Significant Accounting Policies (Details Narrative) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
	item	item
Advertising Expense	$56,219	$73,772
Research and development costs	$80,689	$96,117
Total revenues	10.00%	10.00%
Concentration Risk, Percentage	92.00%	90.00%
Number of customers	5	3
Accounts receivable	95.00%	95.00%
Attributable customer	'	1
International Distributors [Member]	'	'
Concentration Risk, Percentage	91.00%	83.00%
United States [Member]	'	'
Concentration Risk, Percentage	9.00%	17.00%

Significant_Accounting_Policie2

Significant Accounting Policies (Details) (USD $)	Sep. 30, 2014	Dec. 31, 2013
Derivative liability	$639,637	'
Level 1 [Member]	'	'
Derivative liability	'	'
Level 2 [Member]	'	'
Derivative liability	'	'
Level 3 [Member]	'	'
Derivative liability	$639,637	'

Stockholders_Deficit_Details

Stockholders Deficit (Details) (USD $)	12 Months Ended
	Dec. 31, 2013
2009	'
Warrants Outstanding	4,325,000
Warrant Exercise Price	$0.25
Warrant Expiration Date	'2014
2010	'
Warrants Outstanding	2,570,750
Warrant Exercise Price	$0.25
Warrant Expiration Date	'2016
2011	'
Warrants Outstanding	250,000
Warrant Exercise Price	$0.25
Warrant Expiration Date	'2013
2012	'
Warrants Outstanding	9,825,000
Warrant Exercise Price	$0.10
Warrant Expiration Date	'2017
2013	'
Warrants Outstanding	4,875,000
Warrant Exercise Price	$0.10
Warrant Expiration Date	'2018

Stockholders_Deficit_Details_1

Stockholders Deficit (Details 1) (USD $)	9 Months Ended	12 Months Ended	9 Months Ended	12 Months Ended
	Sep. 30, 2014	Dec. 31, 2013	Sep. 30, 2014	Dec. 31, 2013	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
	Employees and Directors Stock Option	Employees and Directors Stock Option	Non-Employee Stock Option	Non-Employee Stock Option	Warrant [Member]	Warrant [Member]	Warrant [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]	'	'	'	'	'	'	'
Outstanding at beginning of year	9,489,120	'	4,137,599	'	16,970,750	7,145,750	4,325,000
Granted	30,026,000	'	1,555,000	'	4,875,000	9,825,000	2,820,750
Cancelled	-7,070,400	'	-1,352,000	'	'	'	'
Expired	-120,000	'	-2,015,600	'	-250,000	'	'
Options Outstanding at end of year	32,324,720	9,489,120	2,324,999	4,137,599	21,595,750	16,970,750	7,145,750
Exercisable at beginning of period	9,489,120	'	4,132,399	'	'	'	'
Exercisable at end of period	28,991,386	9,489,120	2,324,999	4,132,399	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Roll Forward]	'	'	'	'	'	'	'
Outstanding at beginning of year	$0.41	'	$0.46	'	$0.16	$0.25	$0.25
Granted	$0.10	'	$0.08	'	$0.10	$0.10	$0.25
Cancelled	$0.39	'	$0.48	'	'	'	'
Forfeited, exchanged or expired	$0.25	'	$0.47	'	$0.25	'	'
Weighted average exercise price Outstanding at end of year	$0.13	$0.41	$0.19	$0.46	$0.15	$0.16	$0.25
Exercisable at beginning of period	$0.41	'	$0.46	'	'	'	'
Weighted average exercise price of options exercisable at end of period	$0.13	$0.41	$0.19	$0.46	'	'	'
Weighted Average Remaining Contractual Term [RollForward]	'	'	'	'	'	'	'
Outstanding at end of year	'4 years 2 months 9 days	'1 year 0 months 22 days	'2 years 3 months 4 days	'8 months 23 days	'3 years 4 months 6 days	'3 years 6 months 18 days	'3 years 15 days
Granted	'4 years 5 months 27 days	'	'2 years 11 months 27 days	'	'4 years 3 months 4 days	'4 years 8 months	'4 years 4 months
Exercisable at end of period	'4 years 1 month 28 days	'4 years 4 months 24 days	'2 years 3 months 4 days	'8 months 23 days	'	'	'
Intrinsic Value	$671,031	'	$24,500	'	'	$0	$0

Stockholders_Deficit_Details_2

Stockholders Deficit (Details 2) (Employees and Directors Stock Option, USD $)	9 Months Ended
	Sep. 30, 2014
Employees and Directors Stock Option	'
Weighted-average fair value of options granted	$0.09
Weighted-average assumptions:	'
Risk-free interest rate	0.65%
Dividend yield	'
Expected volatility	1.09%
Expected option life (years)	'2 years 6 months 29 days

Stockholders_Deficit_Details_3

Stockholders Deficit (Details 3) (USD $)

3 Months Ended

9 Months Ended

12 Months Ended

3 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Dec. 31, 2013

Dec. 31, 2012

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Employees

Employees

Employees

Employees

Non-employees

Non-employees

Non-employees

Non-employees

Total non-cash stock-based compensation expense

$71,191

'

$2,438,983

'

'

$71,191

'

$2,355,669

'

'

'

$83,314

$16,875

Stockholders_Deficit_Details_N

Stockholders Deficit (Details Narrative) (USD $)	9 Months Ended		12 Months Ended		3 Months Ended	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Dec. 31, 2013	Dec. 31, 2012	Sep. 30, 2014	Sep. 30, 2014
					Employee and Director awards [Member]	Non-employee awards [Member]
Options granted to non-employee	'	'	'	'	100,000	'
Weighted-average fair value for options price per shares	'	'	'	'	'	$0.05
Proceeds from issuance of shares	$827,724	$466,114	$882,157	$810,000	'	'

Stock_Options_Details

Stock Options (Details) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Employees and Directors Stock Option	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]	'	'
Outstanding at beginning of year	11,497,120	11,993,120
Granted	'	50,000
Expired	-2,008,000	-546,000
Options Outstanding at end of year	9,489,120	11,497,120
Exercisable at end of period	9,489,120	11,497,120
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Roll Forward]	'	'
Outstanding at beginning of year	$0.43	$0.43
Granted	'	$0.09
Expired	$0.53	$0.52
Weighted average exercise price Outstanding at end of year	$0.41	$0.43
Weighted average exercise price of options exercisable at end of period	$0.41	$0.43
Non Employee Stock Option [Member]	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]	'	'
Outstanding at beginning of year	4,781,599	4,785,599
Granted	'	150,000
Expired	-644,000	-154,000
Options Outstanding at end of year	4,137,599	4,781,599
Exercisable at end of period	4,132,399	4,776,399
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Roll Forward]	'	'
Outstanding at beginning of year	$0.49	$0.49
Granted	'	$0.25
Expired	$0.57	$0.32
Weighted average exercise price Outstanding at end of year	$0.46	$0.49
Weighted average exercise price of options exercisable at end of period	$0.46	$0.46

Stock_Options_Details_1

Stock Options (Details 1) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2011
	$0.09 - $0.25	$0.26 - $0.50	$0.09 - $0.50	$0.51 - $1.00	$0.51 - $1.00	$0.10 - $0.50
Exercise Price Range, Lower Range	$0.09	$0.26	$0.09	$0.51	$0.51	$0.10
Exercise Price Range, Upper Range	$0.25	$0.50	$0.50	$1	$1	$0.50
Options Outstanding at end of year	2,435,760	7,053,360	11,341,120	11,341,120	468,000	11,525,120
Weighted-average remaining contractual life (in years)	'1 year	'1 year	'2 years	'1 year	'1 year	'3 years
Weighted average exercise price Outstanding at end of year	$0.20	$0.48	$0.42	$0.96	$0.80	$0.42
Exercisable at end of period	2,435,760	7,053,360	11,341,120	11,341,120	468,000	11,525,120
Weighted average exercise price of options exercisable at end of period	$0.20	$0.48	$0.42	$0.96	$0.80	$0.42

Stock_Options_Details_2

Stock Options (Details 2) (USD $)	3 Months Ended		9 Months Ended	12 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Dec. 31, 2013	Dec. 31, 2012
Total non-cash stock-based compensation expense	$71,191	'	$2,438,983	'	'
Employees and Directors Stock Option	'	'	'	'	'
Total non-cash stock-based compensation expense	'	'	'	'	3,396
Non Employee Stock Option [Member]	'	'	'	'	'
Total non-cash stock-based compensation expense	'	'	'	'	11,457
Stock Option Modifications	'	'	'	'	'
Total non-cash stock-based compensation expense	'	'	'	'	$14,853

Stock_Options_Details_3

Stock Options (Details 3) (Employees and Directors Stock Option, USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Employees and Directors Stock Option	'	'
Weighted-average fair value of options granted	'	$0.07
Valuation and related assumption for option program	'	'
Risk-free interest rate	'	0.74%
Dividend yield	'	'
Expected stock price volatility	'	103.00%
Expected term	'	'5 years

Stock_Options_Details_Narrativ

Stock Options (Details Narrative) (USD $)	9 Months Ended		12 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Dec. 31, 2012	Dec. 31, 2011
Stock-based compensation expense	$16,875	$11,458	$14,853	$106,638
Non Employee Stock Option [Member]	'	'	'	'
Stock-based compensation expense	16,875	11,458	26,976	79,662
Employees and Directors Stock Option	'	'	'	'
Stock-based compensation expense	'	'	$3,396	$26,976

Income_Taxes_Details

Income Taxes (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Income Taxes Details	'	'
NOL carry-forwards	$18,439,000	$17,729,000
Book basis in goodwill in excess of tax basis	-723,000	-659,000
Other intangible assets	277,000	392,000
Non-cash stock-based compensation expense	4,402,000	4,401,000
Non-deductible accruals	1,407,000	1,488,000
Less: Valuation allowance	-24,525,000	-24,010,000
Net deferred tax liability	($723,000)	($659,000)

Income_Taxes_Details_1

Income Taxes (Details 1)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Income Taxes Details 1	'	'
Tax benefit at federal statutory rate	-34.00%	-34.00%
State taxes, net of federal income tax	-6.00%	-6.00%
Change in deferred tax valuation allowance	35.00%	37.00%
Income tax expense	-5.00%	-3.00%

Income_Taxes_Details_Narrative

Income Taxes (Details Narrative) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Income Taxes Details Narrative	'	'
Future taxable income	$46,000,000	$44,000,000
Expiry years	'2033	'

Equity_Commitment_and_Related_1

Equity Commitment and Related Party Transactions (Details Narrative) (USD $)	9 Months Ended
	Sep. 30, 2014	Dec. 31, 2013
Amount available for equity commitments	$500,000	'
Mr. Carr. [Member]	'	'
Short term loans	'	500,000
Loss on conversion of related party notes	$387,500	'

Lease_Commitments_Details

Lease Commitments (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Lease Commitments Details	'	'
2013	'	$46,393
2014	47,206	47,206
2015	47,056	47,056
2016	48,110	48,110
2017	16,154	16,154
2018	'	'
Total minimum lease payments	$158,526	$204,919

Lease_Commitments_Details_Narr

Lease Commitments (Details Narrative) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Lease Commitments Details Narrative	'	'
Rent Expese	$43,457	$43,457

Convertible_Note_Payable_Detai

Convertible Note Payable (Details Narrative) (USD $)	3 Months Ended	9 Months Ended		12 Months Ended
	Sep. 30, 2014	Sep. 30, 2014	Sep. 30, 2013	Dec. 31, 2013	Dec. 31, 2012
Convertible Note Payable	'	'	'	'	'
Deferred financing cost balance	$153,673	$153,673	'	'	'
Original debt discount	'	692,678	'	'	'
Original issuance costs	'	150,000	'	'	'
Amortization of debt discount	'	31,103	'	'	'
Amortization of deferred financing cost	10,877	'	'	'	'
convertible debt	488,425	488,425	'	'	'
Debt discount	'	$31,103	'	'	'

Blencathia_Merger_Details_Narr

Blencathia Merger (Details Narrative) (USD $)	Sep. 30, 2014
Blencathia Merger Details Narrative	'
Accrued expense, current obligation of merger	$190,000

Derivative_Liability_Details

Derivative Liability (Details)	9 Months Ended
	Sep. 30, 2014
Convertible Note [Member] | August 22, 2014 measurement [Member]	'
Stock price volatility	219.00%
Convertible Note [Member] | September 30, 2014 measurement [Member]	'
Stock price volatility	211.00%
Convertible Note [Member] | Probability of default triggering [Member]	'
Stock price volatility	0.00%
Convertible Note [Member] | Probability of the Company redeeming the convertible note [Member]	'
Stock price volatility	0.00%
Warrant [Member] | June 30, 2014 [Member]	'
Stock price volatility	225.00%
Warrant [Member] | August 22, 2014 [Member]	'
Stock price volatility	219.00%
Warrant [Member] | September 30, 2014 [Member]	'
Stock price volatility	211.00%

Derivative_Liability_Details_1

Derivative Liability (Details 1) (USD $)	9 Months Ended
	Sep. 30, 2014
Derivative Liability Details 1	'
Derivative liability, Beginning Balance	'
Debt discount due to convertible note	295,773
Debt discount due to warrant issued with debt	246,905
Deferred financing cost due to derivative liability for placement agent warrant	29,550
Loss on change of fair value	67,409
Derivative liability, Ending Balance	$639,637

Derivative_Liability_Details_N

Derivative Liability (Details Narrative) (USD $)	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013	Dec. 31, 2013	Dec. 31, 2012
Derivative Liability Details Narrative	'	'	'	'	'	'
Total convertible debt and warrant's derivative liability	'	'	$639,637	'	'	'
Loss on derivative liability	($234,591)	'	$67,409	'	'	'

Legal_Proceedings_Details_Narr

Legal Proceedings (Details Narrative) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Legal Proceedings Details Narrative	'	'
Balance liability	$190,000	$190,000

Deferred_Revenue_Details_Narra

Deferred Revenue (Details Narrative) (USD $)	3 Months Ended			9 Months Ended		12 Months Ended
	Sep. 30, 2014	Mar. 31, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013	Dec. 31, 2013	Dec. 31, 2012
Deferred Revenue Details Narrative	'	'	'	'	'	'	'
Gain on deferred revenue liability	'	$3,000,000	'	($2,998,242)	'	'	'

Notes_Payable_Related_Parties_

Notes Payable - Related Parties (Details Narrative) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Notes Payable - Related Parties Details Narrative	'	'
Advances from related parties	$450,000	$260,000
Payment made to related parties	100,000	0
Due to related parties	$550,000	$200,000

Accounts_Payable_Details_Narra

Accounts Payable (Details Narrative) (USD $)	Sep. 30, 2014
Payables and Accruals [Abstract]	'
Gain on write off of accounts payable	$59,899
No longer obligated to present accounts payable	$59,889